Medication overuse headache
Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is...
Saved in:
Published in | Nature reviews. Disease primers Vol. 9; no. 1; p. 5 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
02.02.2023
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption.
Medication overuse headache is a secondary headache disorder that occurs in those with a primary headache disorder (commonly tension-type headache or migraine). This Primer reviews the epidemiology, pathophysiology, diagnosis and treatment of medication overuse headache, and discusses how this disorder affects the quality of life of patients. |
---|---|
AbstractList | Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption. Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption.Medication overuse headache is a secondary headache disorder that occurs in those with a primary headache disorder (commonly tension-type headache or migraine). This Primer reviews the epidemiology, pathophysiology, diagnosis and treatment of medication overuse headache, and discusses how this disorder affects the quality of life of patients. Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption. Medication overuse headache is a secondary headache disorder that occurs in those with a primary headache disorder (commonly tension-type headache or migraine). This Primer reviews the epidemiology, pathophysiology, diagnosis and treatment of medication overuse headache, and discusses how this disorder affects the quality of life of patients. Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption.Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized. As MOH is both preventable and treatable, it warrants greater attention and awareness. The diagnosis of MOH is based on the history and an unremarkable neurological examination, and is made according to the diagnostic criteria of the International Classification of Headache Disorders third edition (ICHD-3). Pathophysiological mechanisms of MOH include altered descending pain modulation, central sensitization and biobehavioural factors. Treatment of MOH includes the use of headache preventive therapies, but essential to success is eliminating the cause, by reducing the frequency of use of acute headache medication, and perhaps withdrawing the overused medication altogether. Appropriate treatment is usually highly effective, leading to reduced headache burden and acute medication consumption. |
ArticleNumber | 5 |
Author | Terwindt, Gisela M. Steiner, Timothy J. Lipton, Richard B. Jensen, Rigmor H. Ashina, Sait Schwedt, Todd J. Porreca, Frank Tassorelli, Cristina Diener, Hans-Christoph Lee, Mi Ji |
Author_xml | – sequence: 1 givenname: Sait orcidid: 0000-0003-3973-6640 surname: Ashina fullname: Ashina, Sait email: sashina@bidmc.harvard.edu organization: BIDMC Comprehensive Headache Center, Department of Neurology and Department of Anaesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen – sequence: 2 givenname: Gisela M. surname: Terwindt fullname: Terwindt, Gisela M. organization: Department of Neurology, Leiden University Medical Center – sequence: 3 givenname: Timothy J. orcidid: 0000-0002-1882-4337 surname: Steiner fullname: Steiner, Timothy J. organization: Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Division of Brain Sciences, Imperial College London, Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen – sequence: 4 givenname: Mi Ji orcidid: 0000-0003-1364-1969 surname: Lee fullname: Lee, Mi Ji organization: Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine – sequence: 5 givenname: Frank surname: Porreca fullname: Porreca, Frank organization: Department of Pharmacology, Arizona Health Sciences Center, University of Arizona – sequence: 6 givenname: Cristina orcidid: 0000-0003-1513-2113 surname: Tassorelli fullname: Tassorelli, Cristina organization: Department of Brain and Behavioral Sciences, University of Pavia, Headache Science & Neurorehabilitation Center, IRCCS C. Mondino Foundation – sequence: 7 givenname: Todd J. surname: Schwedt fullname: Schwedt, Todd J. organization: Department of Neurology, Mayo Clinic – sequence: 8 givenname: Rigmor H. orcidid: 0000-0001-6433-5887 surname: Jensen fullname: Jensen, Rigmor H. organization: Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen – sequence: 9 givenname: Hans-Christoph orcidid: 0000-0002-6556-8612 surname: Diener fullname: Diener, Hans-Christoph organization: Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen – sequence: 10 givenname: Richard B. orcidid: 0000-0003-2652-2897 surname: Lipton fullname: Lipton, Richard B. organization: Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Montefiore Headache Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36732518$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1Lw0AQhhep2Fr7BxSk4MVLdPZ7c5TiF1S8KHhbNputTUmTupsI_nu3TYvSQw_DzOF5h5nnFPWqunIInWO4wUDVbWCYS5IAiQVxTuAIDQhwkQgpPnr_5j4ahbAAAMyVSJU4QX0qJCUcqwG6eHF5YU1T1NW4_na-DW48dyY3du7O0PHMlMGNtn2I3h_u3yZPyfT18XlyN00slbxJBOSM56myglliaJal1GZg8pzilAnBGMOYUymcZIwQI8BayVVGOc9ErkDSIbru9q58_dW60OhlEawrS1O5ug2aSEkxwQAiold76KJufRWvW1NYEcJwGqnLLdVmS5frlS-Wxv_o3dsRUB1gfR2CdzNti2YjofGmKDUGvZasO8k6StYbyRpilOxFd9sPhmgXChGuPp3_O_tA6heZ6Ynt |
CitedBy_id | crossref_primary_10_1002_ana_26842 crossref_primary_10_1186_s12883_023_03516_9 crossref_primary_10_1186_s10194_024_01789_0 crossref_primary_10_1186_s10194_023_01554_9 crossref_primary_10_1177_03331024241269735 crossref_primary_10_1177_03331024231202240 crossref_primary_10_1007_s15005_024_4229_8 crossref_primary_10_1016_j_envint_2024_108776 crossref_primary_10_1155_2024_2042069 crossref_primary_10_3389_fphar_2024_1496621 crossref_primary_10_3390_jcm13237491 crossref_primary_10_1007_s11916_024_01290_y crossref_primary_10_1016_j_tins_2024_08_009 crossref_primary_10_3390_jcm13206070 crossref_primary_10_3390_brainsci14010085 crossref_primary_10_1016_S1474_4422_24_00072_3 crossref_primary_10_1186_s10194_024_01759_6 crossref_primary_10_3390_toxins16050221 crossref_primary_10_1111_head_14801 crossref_primary_10_1186_s10194_023_01707_w crossref_primary_10_1016_j_heliyon_2024_e30417 crossref_primary_10_1186_s10194_024_01811_5 crossref_primary_10_14412_2074_2711_2024_5_38_44 crossref_primary_10_1177_03331024241252666 crossref_primary_10_1186_s10194_023_01685_z crossref_primary_10_1177_03331024241245658 crossref_primary_10_1212_CON_0000000000001403 crossref_primary_10_1007_s00415_023_11880_2 crossref_primary_10_1002_ejp_2270 crossref_primary_10_14412_2074_2711_2024_1S_52_58 crossref_primary_10_1007_s10072_024_07496_7 crossref_primary_10_1159_000538528 crossref_primary_10_1177_03331024251317446 crossref_primary_10_1186_s10194_025_01992_7 crossref_primary_10_1016_j_neurol_2024_10_003 crossref_primary_10_1186_s10194_024_01760_z crossref_primary_10_1186_s12883_023_03477_z crossref_primary_10_1177_03331024231184909 crossref_primary_10_1007_s11916_023_01157_8 crossref_primary_10_1186_s10194_024_01748_9 crossref_primary_10_1186_s10194_024_01907_y crossref_primary_10_1212_WNL_0000000000209584 crossref_primary_10_2217_pmt_2023_0106 crossref_primary_10_3389_fneur_2024_1529874 crossref_primary_10_3390_ph18020139 crossref_primary_10_1186_s10194_023_01699_7 crossref_primary_10_3390_jpm13081255 crossref_primary_10_1186_s10194_024_01900_5 crossref_primary_10_1186_s10194_024_01902_3 crossref_primary_10_1080_17425255_2024_2409253 crossref_primary_10_1080_14728214_2023_2288334 crossref_primary_10_1186_s10194_024_01731_4 crossref_primary_10_1186_s10194_024_01755_w crossref_primary_10_1155_2023_6685372 crossref_primary_10_1186_s12883_025_04039_1 crossref_primary_10_14412_2074_2711_2024_6_21_27 crossref_primary_10_62087_hpr_2024_0023 crossref_primary_10_1007_s11916_024_01271_1 crossref_primary_10_1186_s10194_024_01775_6 crossref_primary_10_1038_s41598_024_69349_9 crossref_primary_10_1556_650_2024_33181 crossref_primary_10_1007_s40261_025_01433_y crossref_primary_10_1016_j_ynpai_2025_100179 crossref_primary_10_17116_jnevro202312311164 crossref_primary_10_1186_s10194_024_01873_5 crossref_primary_10_1111_head_14667 crossref_primary_10_1111_head_14862 crossref_primary_10_1186_s10194_024_01935_8 crossref_primary_10_1186_s10194_024_01814_2 crossref_primary_10_1001_jamaneurol_2024_3043 crossref_primary_10_1038_s41582_023_00842_x crossref_primary_10_1186_s10194_024_01932_x crossref_primary_10_14412_2074_2711_2024_1S_12_18 crossref_primary_10_14412_2074_2711_2024_1S_59_65 crossref_primary_10_7759_cureus_72347 crossref_primary_10_1186_s10194_023_01590_5 |
Cites_doi | 10.1111/j.1526-4610.2007.00999.x 10.1016/j.euroneuro.2014.03.010 10.1177/0333102413512033 10.1016/S0306-4522(02)00452-9 10.1186/s10194-017-0734-1 10.1111/head.14108 10.1016/j.pain.2011.12.008 10.1007/s10194-007-0361-3 10.1177/0333102412462638 10.1111/head.12031 10.1177/0333102414521508 10.1111/j.1526-4610.2006.00309.x 10.3892/etm.2021.9976 10.1186/1129-2377-15-5 10.1111/j.1468-2982.2009.01859.x 10.1186/s10194-017-0759-5 10.1055/s-0038-1646946 10.1111/head.13209 10.1097/WCO.0b013e328346af25 10.1212/WNL.0000000000012723 10.1111/head.12223 10.1186/s10194-017-0741-2 10.1111/ene.12732 10.1212/WNL.0000000000003760 10.1177/0883073807307090 10.1177/0333102420931050 10.1177/0333102417738202 10.1186/s10194-016-0649-2 10.1186/1129-2377-14-59 10.1001/jamaneurol.2020.1179 10.1212/WNL.0000000000011216 10.1177/0333102411402367 10.1111/head.14036 10.1007/s11916-013-0370-7 10.1177/0333102409355600 10.1016/S0306-4522(00)00226-8 10.1177/0333102416630593 10.1186/s10194-016-0704-z 10.1111/head.13459 10.1111/head.12487 10.1016/S0304-3959(00)00478-4 10.1146/annurev.ph.49.030187.002213 10.1111/j.1526-4610.2008.01257.x 10.1186/s10194-022-01471-3 10.1111/head.14153 10.2147/NDT.S8467 10.1177/0333102418783317 10.1126/science.aap8757 10.1177/0333102417736898 10.1186/s10194-019-1061-5 10.1111/j.1526-4610.1994.hed3401001.x 10.1097/ADM.0000000000000504 10.1186/1471-2377-10-126 10.1007/s11916-018-0734-0 10.1111/j.1526-4610.1988.hed2801060_2.x 10.3389/fneur.2019.01336 10.1212/WNL.59.7.1011 10.1177/0333102419876907 10.1016/j.pain.2011.08.018 10.1016/S0140-6736(20)32544-7 10.1177/0333102418786265 10.1007/s10072-008-0867-8 10.1177/03331024221099031 10.1007/s11916-011-0240-0 10.1056/NEJMoa1813049 10.1186/1129-2377-15-86 10.1212/WNL.0000000000004177 10.1111/head.13037 10.1177/0333102415593088 10.1177/0333102414520768 10.1177/0333102413515344 10.1056/NEJMoa1811090 10.1093/brain/awz052 10.1111/j.1468-2982.2006.01175.x 10.1038/s41431-018-0150-2 10.1186/s10194-020-1081-1 10.1111/j.1526-4610.2008.01217.x 10.1111/j.1526-4610.2006.00684.x 10.1016/j.tins.2020.06.003 10.1152/jn.00632.2015 10.1111/ene.15256 10.1016/S1474-4422(10)70054-5 10.1186/s10194-020-01179-2 10.1186/s10194-018-0875-x 10.1016/j.npep.2015.03.008 10.1111/head.13194 10.1212/01.wnl.0000263652.46222.e8 10.1177/0333102416640501 10.1186/s10194-018-0865-z 10.1186/s10194-021-01248-0 10.1186/1129-2377-14-10 10.1177/0333102413515338 10.1177/0333102412475235 10.1186/s10194-020-01173-8 10.1186/1129-2377-15-10 10.1111/j.1468-2982.2004.00789.x 10.1186/1129-2377-15-3 10.1007/s10072-009-0081-3 10.1177/0333102418804157 10.1016/j.pediatrneurol.2014.01.040 10.1053/eujp.1999.0154 10.1111/head.13120 10.1093/brain/awh691 10.1177/0333102416683918 10.1177/0333102419883355 10.1007/s10194-010-0285-1 10.1212/01.WNL.0000123262.96132.FC 10.1007/s11916-019-0796-7 10.1186/s10194-016-0679-9 10.1177/03331024211010306 10.1111/j.1468-2982.2007.01326.x 10.1056/NEJMoa2035908 10.1111/head.13641 10.1111/j.1526-4610.2012.02170.x 10.1212/WNL.0000000000006697 10.1177/0333102411410082 10.1007/s40263-021-00818-9 10.1046/j.1526-4610.2003.03041.x 10.3389/fnint.2018.00042 10.1056/NEJMra1915327 10.1186/s10194-021-01228-4 10.1016/S1474-4422(19)30146-2 10.1177/0333102420974362 10.1177/03331024211039813 10.3390/ijerph192114116 10.1080/00207454.2022.2126773 10.1177/03331024211068813 10.1111/head.14056 10.1046/j.1468-2982.2001.00288.x 10.1177/0333102420920006 10.1016/S0140-6736(15)60692-4 10.1136/jnnp-2014-308548 10.1111/j.1526-4637.2011.01183.x 10.1177/03331024211006903 10.1186/s10194-016-0696-8 10.1111/j.1468-2982.2008.01711.x 10.1212/01.wnl.0000260607.90634.d6 10.1016/j.jns.2013.05.003 10.1007/s11916-014-0428-1 10.1016/j.pain.2014.07.002 10.1016/j.neucli.2020.11.002 10.1046/j.1526-4610.2000.00052.x 10.1111/ene.14268 10.1111/j.1468-2982.2005.00878.x 10.1186/s10194-022-01477-x 10.1093/pm/pny084 10.1046/j.1468-2982.2003.00648.x 10.1177/0333102412451363 10.1038/s41588-021-00990-0 10.1177/0333102417728244 10.1111/j.1468-2982.2009.01914.x 10.1176/appi.neuropsych.20070189 10.1111/j.1468-2982.2005.00879.x 10.1016/S2215-0366(18)30337-7 10.1186/s10194-020-01175-6 10.1111/head.12350 10.1111/j.1526-4610.2011.02061.x 10.1177/0333102412438977 10.1177/0333102417702120 10.1007/s11916-009-0065-2 10.1111/ene.12424 10.1111/head.14018 10.1212/WNL.0000000000005857 10.1177/0333102419876909 10.3389/fneur.2020.00226 10.3109/15622975.2012.665175 10.1007/s10194-009-0136-0 10.1177/0333102420938652 10.1177/0333102418762525 10.1186/s12877-022-03027-1 10.1111/j.1468-2982.2004.00691.x 10.1111/j.1468-1331.2011.03612.x 10.1111/ene.12850 10.1186/s10194-017-0763-9 10.1111/j.1468-2982.2009.01934.x 10.1177/0333102411420585 10.1093/brain/awr272 10.3389/fneur.2019.00173 10.1186/s10194-015-0549-x 10.1136/jnnp.2009.198101 10.1016/0304-3940(80)90306-7 10.1007/s10072-019-03865-9 10.5152/npa.2015.8799 10.1177/0333102415578430 10.1111/j.1468-2982.2006.01183.x 10.1186/s10194-015-0580-y 10.1212/WNL.0000000000004371 10.1177/003335490912400206 10.1186/s10194-020-01146-x 10.1186/s10194-021-01224-8 10.1111/j.1526-4610.2011.02050.x 10.1111/head.14363 10.1111/j.1526-4610.2010.01711.x 10.1016/S0304-3959(03)00293-8 10.1212/WNL.0b013e3182825055 10.1111/ane.12692 10.1016/j.jpain.2009.06.012 10.1016/S0140-6736(19)31606-X 10.1523/JNEUROSCI.22-18-08312.2002 10.1038/s41572-021-00257-2 10.1016/j.tips.2004.12.008 10.1212/WNL.0000000000007497 10.1212/WNL.0000000000200117 10.1093/brain/awq159 10.1177/0333102417737779 10.1172/JCI43766 10.1177/0333102420966658 10.1177/0333102415583146 10.1007/s10194-011-0313-9 10.1016/j.neuropharm.2021.108456 10.1111/j.1468-2982.2008.01577.x 10.1111/ene.12794 10.1177/0333102413485658 10.1177/0333102416672493 10.1111/j.1526-4610.2010.01695.x 10.1111/j.1526-4610.2006.00560.x 10.1038/nrneurol.2016.124 10.3109/02688697.2014.950633 10.1111/head.12408 10.1177/0333102409357958 10.1097/MD.0000000000008493 10.1212/CPJ.0000000000001037 10.1186/s10194-022-01420-0 10.1177/0333102410373155 10.1186/s10194-022-01402-2 10.1002/ejp.1383 10.1097/AJP.0b013e3182321d35 10.1016/S0140-6736(16)31678-6 10.1177/0333102416660549 10.1186/s10194-018-0848-0 10.1007/s10194-008-0061-7 10.1016/j.clinph.2020.10.014 10.36076/ppj.2012/15/245 10.1177/0333102412461890 10.1177/03331024221103814 10.1007/s10194-010-0221-4 10.1212/WNL.94.15_supplement.1793 10.1111/j.1468-2982.2009.02022.x 10.1016/bs.pbr.2020.05.019 10.1111/j.1468-2982.2003.00824.x 10.1002/ana.21897 10.1046/j.1468-2982.1988.0801001.x |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. Springer Nature Limited. |
Copyright_xml | – notice: Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. Springer Nature Limited. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1038/s41572-022-00415-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2056-676X |
ExternalDocumentID | 36732518 10_1038_s41572_022_00415_0 |
Genre | Journal Article Review |
GroupedDBID | 0R~ 53G 7X7 88I 8FI 8FJ AAEEF AARCD AAWYQ AAYZH AAZLF ABJNI ABLJU ABUWG ACGFS ACMJI ADBBV AFKRA AFSHS AGAYW AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD AZQEC BENPR BKKNO BPHCQ BVXVI CCPQU DWQXO EBS FQGFK FSGXE FYUFA FZEXT GNUQQ HCIFZ HMCUK LGEZI LOTEE M2P NADUK NNMJJ NXXTH PQQKQ PROAC R9- RNR RNT SHXYY SIXXV SNYQT SOJ TAOOD TBHMF TDRGL TSG UKHRP AAYXX ABFSG ACMFV ACSTC AEZWR AFANA AFHIU AHWEU AIXLP ATHPR BBNVY BHPHI CITATION M7P NFIDA PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c375t-60d45d98c64c2a3bb93cb0add319466444115376e74422a60cc758b355b6d8073 |
IEDL.DBID | 7X7 |
ISSN | 2056-676X |
IngestDate | Fri Jul 11 13:03:48 EDT 2025 Sat Aug 23 14:58:34 EDT 2025 Thu Apr 03 07:07:52 EDT 2025 Tue Jul 01 02:52:22 EDT 2025 Thu Apr 24 23:10:58 EDT 2025 Fri Feb 21 02:37:56 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2023. Springer Nature Limited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-60d45d98c64c2a3bb93cb0add319466444115376e74422a60cc758b355b6d8073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0001-6433-5887 0000-0003-1364-1969 0000-0003-1513-2113 0000-0003-2652-2897 0000-0002-6556-8612 0000-0002-1882-4337 0000-0003-3973-6640 |
PMID | 36732518 |
PQID | 2771822419 |
PQPubID | 2069613 |
ParticipantIDs | proquest_miscellaneous_2773121006 proquest_journals_2771822419 pubmed_primary_36732518 crossref_citationtrail_10_1038_s41572_022_00415_0 crossref_primary_10_1038_s41572_022_00415_0 springer_journals_10_1038_s41572_022_00415_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-02-02 |
PublicationDateYYYYMMDD | 2023-02-02 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-02 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature reviews. Disease primers |
PublicationTitleAbbrev | Nat Rev Dis Primers |
PublicationTitleAlternate | Nat Rev Dis Primers |
PublicationYear | 2023 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Liu (CR115) 2022 Dodick (CR258) 2019; 381 De Felice, Ossipov, Porreca (CR121) 2011; 24 Tassorelli (CR161) 2017; 37 (CR3) 1988; 8 Benz (CR254) 2017; 96 Yu (CR17) 2012; 52 MacGregor (CR109) 2009; 13 Phillips (CR82) 1987; 49 Togha (CR28) 2022; 42 Zidverc-Trajkovic (CR241) 2018; 38 Fuxe (CR85) 1980; 22 Rastenytė (CR21) 2017; 18 Carlsen, Westergaard, Bisgaard, Schytz, Jensen (CR188) 2018; 38 Dodick (CR185) 2003; 3 Jellestad (CR183) 2019; 39 Belanger, Ma, Chabot, Quirion (CR141) 2002; 115 Boe, Mygland, Salvesen (CR210) 2007; 69 Hagen (CR252) 2011; 12 Fumal (CR114) 2006; 129 De Felice (CR145) 2010; 67 Rosignoli (CR75) 2022; 23 Zebenigus, Tekle-Haimanot, Worku, Thomas, Steiner (CR25) 2016; 17 Pompili (CR44) 2010; 6 Pini, Cicero, Sandrini (CR245) 2001; 21 Di Lorenzo (CR78) 2012; 32 Pijpers, Kies, van Zwet, Rosendaal, Terwindt (CR162) 2022; 29 Marmura (CR128) 2018; 22 Sarchielli (CR215) 2014; 24 Rausa (CR225) 2016; 17 Mbewe (CR24) 2015; 16 Grazzi (CR230) 2020; 40 Ailani (CR257) 2021; 385 Fuh, Wang (CR93) 2012; 16 van Casteren, Kurth, Danser, Terwindt, MaassenVanDenBrink (CR108) 2021; 96 Yisarakun (CR143) 2015; 51 Schytz (CR208) 2021; 22 Young (CR12) 2018; 58 (CR65) 2004; 24 Taghdiri, Togha, Razeghi Jahromi, Paknejad (CR213) 2015; 55 Limmroth, Katsarava, Fritsche, Przywara, Diener (CR175) 2002; 59 Anttila (CR87) 2018; 360 De Felice (CR146) 2010; 133 Scher, Rizzoli, Loder (CR196) 2017; 89 Schwedt (CR256) 2021; 11 Becerra (CR150) 2016; 115 Wang, Yu, Kuan, Chen, Wang (CR42) 2021; 22 De Icco (CR231) 2021; 132 Steiner (CR68) 2022; 23 Sancisi (CR54) 2010; 50 Grazzi (CR226) 2022; 19 Lai (CR111) 2016; 36 Bottiroli (CR206) 2019; 10 Navratilova (CR171) 2020; 40 Calabresi, Cupini (CR147) 2005; 26 Ménard (CR144) 1995; 273 Ayzenberg (CR151) 2006; 26 Supornsilpchai, le Grand, Srikiatkhachorn (CR148) 2010; 30 Scher (CR193) 2017; 89 Westergaard, Glümer, Hansen, Jensen (CR55) 2016; 36 Schwedt (CR5) 2018; 19 Shah, Bendtsen, Zeeberg, Jensen (CR249) 2013; 53 Kawatu (CR31) 2022; 23 Cargnin, Viana, Sances, Tassorelli, Terrazzino (CR81) 2018; 38 Altintaş, Karakurum Göksel, Taşkintuna, Saritürk (CR253) 2015; 52 Deen (CR154) 2017; 37 Andrasik, Grazzi, Usai, Buse, Bussone (CR222) 2009; 30 Tassorelli (CR237) 2018; 91 Björkman (CR157) 1995; 103 Riederer (CR112) 2012; 13 Darmani, Martin, Glennon (CR158) 1992; 262 Hein (CR127) 2021; 185 Latremoliere, Woolf (CR122) 2009; 10 Pakalnis, Butz, Splaingard, Kring, Fong (CR43) 2007; 22 Pini, Vitale, Ottani, Sandrini (CR156) 1997; 280 Diener (CR218) 2009; 29 Xie (CR126) 2017; 37 van Casteren (CR107) 2021; 97 Xu, Kong, Buse (CR118) 2019; 40 Manandhar, Risal, Steiner, Holen, Linde (CR18) 2015; 16 Haulică, Petrescu, Uluitu, Roşca, Slătineanu (CR84) 1980; 18 Croop (CR220) 2021; 397 Lipton (CR259) 2019; 381 Hagen (CR201) 2009; 29 Bigal (CR6) 2008; 48 Grazzi, Andrasik, Usai, Bussone (CR243) 2008; 29 Cargnin (CR80) 2014; 21 Schoenen (CR232) 2013; 80 Saylor, Steiner (CR51) 2018; 38 (CR99) 2018; 5 Bottiroli (CR45) 2018; 39 Radat, Chanraud, Di Scala, Dousset, Allard (CR90) 2013; 14 Ljubisavljevic, Ignjatovic, Djordjevic, Pesic, Ljubisavljevic (CR250) 2021; 33 Luvsannorov (CR16) 2019; 20 Ashina (CR119) 2020; 383 Ma, Zheng, Kar, Quirion (CR142) 2000; 99 Munksgaard, Bendtsen, Jensen (CR224) 2012; 32 Di Lorenzo (CR79) 2009; 10 van Casteren (CR186) 2021; 41 Green (CR149) 2014; 34 Paemeleire (CR229) 2010; 30 Zwart (CR11) 2004; 62 Dodick (CR167) 2021; 41 Lagman-Bartolome, Lawler, Lay (CR190) 2018; 58 Diener (CR198) 2020; 27 Luvsannorov (CR30) 2020; 21 Saper, Hamel, Lake (CR95) 2005; 25 Steiner (CR70) 2014; 15 Schwedt (CR203) 2022; 98 Sarchielli (CR40) 2016; 23 Ossipov, Dussor, Porreca (CR123) 2010; 120 Sun-Edelstein, Rapoport, Rattanawong, Srikiatkhachorn (CR72) 2021; 35 Munksgaard, Jensen (CR165) 2014; 54 Lance, Parkes, Wilkinson (CR73) 1988; 28 Mao, Sung, Ji, Lim (CR255) 2002; 22 Carlsen (CR164) 2020; 77 Munksgaard, Bendtsen, Jensen (CR134) 2013; 33 CR15 Scher, Stewart, Ricci, Lipton (CR194) 2003; 106 CR13 Peters, Horton (CR1) 1951; 26 Cevoli (CR96) 2009; 49 Jonsson, Hedenrud, Linde (CR35) 2011; 31 Silberstein (CR64) 2005; 25 Krymchantowski, Moreira (CR209) 2003; 23 Kristoffersen, Straand, Russell, Lundqvist (CR39) 2016; 23 Yarnitsky (CR238) 2017; 88 Radat (CR91) 2008; 48 Rossi, Faroni, Tassorelli, Nappi (CR160) 2013; 14 Hagen, Linde, Steiner, Stovner, Zwart (CR9) 2012; 153 Zewde (CR27) 2020; 21 Marmura, Lin, Harris, Ironi, Rosen (CR239) 2020; 11 Ferraro (CR117) 2012; 13 Takahashi (CR88) 2021; 22 Oh (CR181) 2022; 62 Aaseth (CR36) 2008; 28 Barbanti (CR97) 2019; 40 Buse, Greisman, Baigi, Lipton (CR8) 2019; 59 Nation, Dodick, Navratilova, Porreca (CR130) 2019; 39 van Casteren, Verhagen, Onderwater, MaassenVanDenBrink, Terwindt (CR102) 2021; 41 Rossi, Di Lorenzo, Faroni, Cesarino, Nappi (CR199) 2006; 26 Buse (CR94) 2012; 52 Grosse, Lollar, Campbell, Chamie (CR58) 2009; 124 Peres (CR101) 2007; 8 Coppola (CR152) 2010; 10 Rabe (CR211) 2013; 33 Al Jumah (CR22) 2020; 21 Messlinger (CR140) 2018; 19 Ailani, Burch, Robbins (CR174) 2021; 61 Thorlund (CR182) 2016; 17 McGinley (CR173) 2020; 94 Hautakangas (CR77) 2022; 54 Westergaard, Lau, Allesøe, Gjendal, Jensen (CR34) 2020; 40 Serra, Marchioretto (CR228) 2012; 15 Martin, Behbehani (CR104) 2006; 46 Hedenrud, Babic, Jonsson (CR189) 2014; 54 Filatova, Latysheva, Kurenkov (CR135) 2008; 9 Viana (CR48) 2019; 59 Loder, Scher (CR61) 2020; 40 Pijpers (CR223) 2016; 36 Schwedt (CR49) 2021; 61 Lundqvist, Grande, Aaseth, Russell (CR92) 2012; 153 Genc (CR29) 2020; 21 Ashina (CR153) 2021; 7 Herekar (CR23) 2017; 18 Chen, Navratilova, Dodick, Porreca (CR106) 2020; 43 Silberstein (CR168) 2020; 21 Schwedt (CR46) 2021; 41 Da Silva, Lake (CR76) 2014; 54 Le Bars, Villanueva, Bouhassira, Willer (CR124) 1992; 4 Schou, Ashina, Amin, Goadsby, Ashina (CR139) 2017; 18 Croop (CR172) 2019; 394 Carlsen, Munksgaard, Jensen, Bendtsen (CR204) 2018; 38 Karadas, Ozon, Ozcelik, Ozge (CR221) 2017; 135 Tassorelli (CR207) 2014; 34 Eikermann-Haerter (CR159) 2009; 119 CR57 Lake (CR98) 2006; 46 CR56 Grazzi (CR116) 2010; 50 Bahra, Walsh, Menon, Goadsby (CR74) 2003; 43 Westergaard, Hansen, Glümer, Olesen, Jensen (CR2) 2014; 34 Siberstein, Lipton, Solomon, Mathew (CR66) 1994; 34 Linde (CR60) 2012; 19 Chen, Wang (CR197) 2019; 23 Vos (CR59) 2015; 386 Lundqvist, Gossop, Russell, Straand, Kristoffersen (CR89) 2019; 13 Hagen, Jensen, Bøe, Stovner (CR195) 2010; 11 Vacca (CR240) 2018; 19 Heyer, Idris (CR179) 2014; 50 Silberstein (CR216) 2013; 331 Goadsby (CR219) 2022; 42 Popescu, Marian, Drăgoi, Costea (CR100) 2021; 21 Westergaard, Glümer, Hansen, Jensen (CR33) 2014; 155 Wilkinson (CR234) 2017; 57 Ikegami (CR132) 2022; 42 Diener (CR214) 2007; 27 CR67 Lipton (CR235) 2010; 9 Meng, Dodick, Ossipov, Porreca (CR131) 2011; 31 Hoffmann, Recober (CR129) 2013; 17 Willer, Jensen, Juhler (CR177) 2010; 81 Bøe, Thortveit, Vatne, Mygland (CR242) 2017; 37 Schwedt, Chong (CR110) 2017; 57 Stovner, Hagen, Linde, Steiner (CR26) 2022; 23 Tepper (CR169) 2019; 92 Perrotta (CR138) 2010; 30 Engelstoft (CR205) 2019; 23 Yang (CR227) 2011; 31 Lai (CR187) 2014; 15 Lampl (CR37) 2016; 17 He (CR52) 2015; 22 Sances (CR246) 2010; 30 Vandenbussche (CR41) 2018; 19 Togha (CR53) 2022; 22 Bendtsen (CR38) 2014; 34 (CR63) 2013; 33 deSouza, Toma, Watkins (CR178) 2015; 29 Rau (CR260) 2020; 40 Bigal, Rapoport, Sheftell, Tepper, Lipton (CR7) 2004; 24 Kristoffersen (CR200) 2015; 86 Steiner (CR62) 2014; 34 Verhagen (CR103) 2022; 42 (CR4) 2018; 38 Cevoli (CR212) 2017; 18 Hershey, Burdine, Kabbouche, Powers (CR247) 2011; 31 Wang, Juang, Fuh, Lu (CR50) 2007; 68 Katsarava (CR244) 2005; 25 Ayzenberg (CR20) 2012; 32 CR83 Kulkarni, Rao, Gururaj, Stovner, Steiner (CR19) 2015; 16 Eide (CR166) 2000; 4 Silberstein (CR217) 2007; 47 Starling (CR236) 2018; 38 Gelfand, Goadsby (CR248) 2014; 18 Burstein (CR120) 2001; 89 Ramaswamy, Wodehouse (CR125) 2021; 51 Zebenholzer, Thamer, Wöber (CR251) 2012; 28 (CR14) 2016; 388 Perrotta (CR137) 2012; 52 CR180 Ashina, Dodick (CR10) 2021; 61 Nassini (CR133) 2012; 135 Yang (CR86) 2018; 26 Najib (CR233) 2022; 42 Chiang, Schwedt, Wang, Dodick (CR202) 2016; 36 Do (CR184) 2019; 92 Diener (CR170) 2021; 61 Dussor, Boyd, Akopian (CR105) 2018; 12 Diener (CR71) 2019; 18 Pijpers (CR163) 2019; 142 CR191 Wöber-Bingöl (CR32) 2014; 15 Chong (CR113) 2020; 10 Diener, Holle, Solbach, Gaul (CR47) 2016; 12 Stovner (CR69) 2014; 15 Srikiatkhachorn, Tarasub, Govitrapong (CR155) 2000; 40 Lipton (CR176) 2021; 61 Zappaterra, Guerzoni, Cainazzo, Ferrari, Pini (CR136) 2011; 12 Ashina, Lyngberg, Jensen (CR192) 2010; 30 E Filatova (415_CR135) 2008; 9 C Tassorelli (415_CR207) 2014; 34 M De Felice (415_CR146) 2010; 133 R De Icco (415_CR231) 2021; 132 K Manandhar (415_CR18) 2015; 16 LN Carlsen (415_CR204) 2018; 38 AJ Starling (415_CR236) 2018; 38 Headache Classification Subcommittee of the International Headache Society. (415_CR65) 2004; 24 K Hagen (415_CR9) 2012; 153 RB Lipton (415_CR235) 2010; 9 AI Scher (415_CR194) 2003; 106 AM Shah (415_CR249) 2013; 53 M Zebenigus (415_CR25) 2016; 17 DW Dodick (415_CR167) 2021; 41 K Eikermann-Haerter (415_CR159) 2009; 119 M Togha (415_CR53) 2022; 22 L Bendtsen (415_CR38) 2014; 34 M De Felice (415_CR145) 2010; 67 R Croop (415_CR220) 2021; 397 JL Fuh (415_CR93) 2012; 16 M Ljubisavljevic (415_CR250) 2021; 33 ML Westergaard (415_CR34) 2020; 40 JC Rau (415_CR260) 2020; 40 F Riederer (415_CR112) 2012; 13 Headache Classification Committee of the International Headache Society (IHS). (415_CR4) 2018; 38 ID Meng (415_CR131) 2011; 31 P Rossi (415_CR199) 2006; 26 TJ Schwedt (415_CR46) 2021; 41 AE Lake III (415_CR98) 2006; 46 DP Ménard (415_CR144) 1995; 273 415_CR57 H Ashina (415_CR10) 2021; 61 A Perrotta (415_CR137) 2012; 52 M De Felice (415_CR121) 2011; 24 J Ailani (415_CR257) 2021; 385 DC Buse (415_CR8) 2019; 59 ES Kristoffersen (415_CR39) 2016; 23 415_CR56 L Grazzi (415_CR243) 2008; 29 I Ayzenberg (415_CR20) 2012; 32 M Deen (415_CR154) 2017; 37 M Zappaterra (415_CR136) 2011; 12 AV Krymchantowski (415_CR209) 2003; 23 LN Carlsen (415_CR164) 2020; 77 M Linde (415_CR60) 2012; 19 E Navratilova (415_CR171) 2020; 40 TJ Schwedt (415_CR49) 2021; 61 P Barbanti (415_CR97) 2019; 40 JTF Lai (415_CR187) 2014; 15 J Mao (415_CR255) 2002; 22 CC Chiang (415_CR202) 2016; 36 C Di Lorenzo (415_CR79) 2009; 10 415_CR67 A Srikiatkhachorn (415_CR155) 2000; 40 GL Heyer (415_CR179) 2014; 50 SD Silberstein (415_CR64) 2005; 25 W Ma (415_CR142) 2000; 99 MJ Marmura (415_CR239) 2020; 11 CD Chong (415_CR113) 2020; 10 I Haulică (415_CR84) 1980; 18 SD Silberstein (415_CR217) 2007; 47 K Hagen (415_CR252) 2011; 12 DS van Casteren (415_CR186) 2021; 41 D Yarnitsky (415_CR238) 2017; 88 JY Xie (415_CR126) 2017; 37 D Wilkinson (415_CR234) 2017; 57 D Ikegami (415_CR132) 2022; 42 L Grazzi (415_CR230) 2020; 40 A Fumal (415_CR114) 2006; 129 N Kawatu (415_CR31) 2022; 23 HC Diener (415_CR47) 2016; 12 LA Pini (415_CR245) 2001; 21 S Ferraro (415_CR117) 2012; 13 TJ Schwedt (415_CR203) 2022; 98 L Grazzi (415_CR226) 2022; 19 SB Munksgaard (415_CR134) 2013; 33 TJ Schwedt (415_CR110) 2017; 57 S Cevoli (415_CR212) 2017; 18 A Latremoliere (415_CR122) 2009; 10 PL Jellestad (415_CR183) 2019; 39 LJ Stovner (415_CR69) 2014; 15 IMS Engelstoft (415_CR205) 2019; 23 M Hein (415_CR127) 2021; 185 G Sances (415_CR246) 2010; 30 GB Kulkarni (415_CR19) 2015; 16 RM deSouza (415_CR178) 2015; 29 L Becerra (415_CR150) 2016; 115 U Najib (415_CR233) 2022; 42 K Aaseth (415_CR36) 2008; 28 S Cevoli (415_CR96) 2009; 49 S Bottiroli (415_CR206) 2019; 10 J Xu (415_CR118) 2019; 40 AI Scher (415_CR196) 2017; 89 DC Buse (415_CR94) 2012; 52 S Belanger (415_CR141) 2002; 115 C Tassorelli (415_CR237) 2018; 91 DS van Casteren (415_CR107) 2021; 97 E Mbewe (415_CR24) 2015; 16 C Sun-Edelstein (415_CR72) 2021; 35 I Ayzenberg (415_CR151) 2006; 26 C Tassorelli (415_CR161) 2017; 37 415_CR13 415_CR15 M Viana (415_CR48) 2019; 59 T Benz (415_CR254) 2017; 96 HC Diener (415_CR71) 2019; 18 EA MacGregor (415_CR109) 2009; 13 K Hagen (415_CR195) 2010; 11 PK Chen (415_CR197) 2019; 23 DS van Casteren (415_CR108) 2021; 96 V Limmroth (415_CR175) 2002; 59 KM Nation (415_CR130) 2019; 39 S Ashina (415_CR153) 2021; 7 LJ Stovner (415_CR26) 2022; 23 SD Silberstein (415_CR168) 2020; 21 K Fuxe (415_CR85) 1980; 22 J Schoenen (415_CR232) 2013; 80 LA Pini (415_CR156) 1997; 280 L Willer (415_CR177) 2010; 81 CP Yang (415_CR227) 2011; 31 Headache Classification Committee of the International Headache Society (IHS). (415_CR63) 2013; 33 MG Boe (415_CR210) 2007; 69 H Hautakangas (415_CR77) 2022; 54 C Lundqvist (415_CR89) 2019; 13 S Yu (415_CR17) 2012; 52 AM Lagman-Bartolome (415_CR190) 2018; 58 R Croop (415_CR172) 2019; 394 JS McGinley (415_CR173) 2020; 94 YZ Zewde (415_CR27) 2020; 21 Ç Wöber-Bingöl (415_CR32) 2014; 15 JJ Zidverc-Trajkovic (415_CR241) 2018; 38 JA Zwart (415_CR11) 2004; 62 M Pompili (415_CR44) 2010; 6 M Togha (415_CR28) 2022; 42 MJ Marmura (415_CR128) 2018; 22 Headache Classification Committee of the International Headache Society (IHS). (415_CR3) 1988; 8 F Andrasik (415_CR222) 2009; 30 P Sarchielli (415_CR215) 2014; 24 TJ Schwedt (415_CR256) 2021; 11 G Serra (415_CR228) 2012; 15 ME Bigal (415_CR7) 2004; 24 ES Kristoffersen (415_CR200) 2015; 86 PJ Goadsby (415_CR219) 2022; 42 O Karadas (415_CR221) 2017; 135 TJ Schwedt (415_CR5) 2018; 19 TJ Steiner (415_CR68) 2022; 23 SY Oh (415_CR181) 2022; 62 DW Dodick (415_CR185) 2003; 3 F Radat (415_CR90) 2013; 14 A Bahra (415_CR74) 2003; 43 415_CR191 SD Silberstein (415_CR216) 2013; 331 W Yisarakun (415_CR143) 2015; 51 A Perrotta (415_CR138) 2010; 30 NA Darmani (415_CR158) 1992; 262 Y Chen (415_CR106) 2020; 43 LN Carlsen (415_CR188) 2018; 38 MF Peres (415_CR101) 2007; 8 SD Grosse (415_CR58) 2009; 124 P Rossi (415_CR160) 2013; 14 HC Diener (415_CR170) 2021; 61 E Sancisi (415_CR54) 2010; 50 GBD 2016 Alcohol and Drug Use Collaborators. (415_CR99) 2018; 5 S Cargnin (415_CR80) 2014; 21 C Lundqvist (415_CR92) 2012; 153 K Hagen (415_CR201) 2009; 29 H Liu (415_CR115) 2022 P Calabresi (415_CR147) 2005; 26 S Cargnin (415_CR81) 2018; 38 AA Herekar (415_CR23) 2017; 18 MI Phillips (415_CR82) 1987; 49 ME Bigal (415_CR6) 2008; 48 SB Munksgaard (415_CR165) 2014; 54 K Rabe (415_CR211) 2013; 33 M Al Jumah (415_CR22) 2020; 21 JR Saper (415_CR95) 2005; 25 F Taghdiri (415_CR213) 2015; 55 HC Diener (415_CR218) 2009; 29 SJ Wang (415_CR50) 2007; 68 S Bottiroli (415_CR45) 2018; 39 EW Loder (415_CR61) 2020; 40 TT Takahashi (415_CR88) 2021; 22 AL Green (415_CR149) 2014; 34 C Lampl (415_CR37) 2016; 17 S Ashina (415_CR192) 2010; 30 ML Westergaard (415_CR33) 2014; 155 R Björkman (415_CR157) 1995; 103 HC Diener (415_CR214) 2007; 27 Y-F Wang (415_CR42) 2021; 22 R Nassini (415_CR133) 2012; 135 HC Diener (415_CR198) 2020; 27 E Altintaş (415_CR253) 2015; 52 ML Westergaard (415_CR2) 2014; 34 SJ Tepper (415_CR169) 2019; 92 K Thorlund (415_CR182) 2016; 17 TP Do (415_CR184) 2019; 92 WB Young (415_CR12) 2018; 58 ML Westergaard (415_CR55) 2016; 36 TH Lai (415_CR111) 2016; 36 L Grazzi (415_CR116) 2010; 50 C Rosignoli (415_CR75) 2022; 23 M Ashina (415_CR119) 2020; 383 SB Munksgaard (415_CR224) 2012; 32 A Vacca (415_CR240) 2018; 19 O Luvsannorov (415_CR30) 2020; 21 D Genc (415_CR29) 2020; 21 S Ramaswamy (415_CR125) 2021; 51 C Di Lorenzo (415_CR78) 2012; 32 G Dussor (415_CR105) 2018; 12 J Ailani (415_CR174) 2021; 61 F Lance (415_CR73) 1988; 28 F Radat (415_CR91) 2008; 48 G Coppola (415_CR152) 2010; 10 JA Pijpers (415_CR223) 2016; 36 DS van Casteren (415_CR102) 2021; 41 Z He (415_CR52) 2015; 22 MH Ossipov (415_CR123) 2010; 120 A Pakalnis (415_CR43) 2007; 22 TJ Steiner (415_CR70) 2014; 15 WS Schou (415_CR139) 2017; 18 Y Yang (415_CR86) 2018; 26 A Popescu (415_CR100) 2021; 21 MG Bøe (415_CR242) 2017; 37 415_CR83 JA Pijpers (415_CR163) 2019; 142 K Messlinger (415_CR140) 2018; 19 AD Hershey (415_CR247) 2011; 31 R Burstein (415_CR120) 2001; 89 AN Da Silva (415_CR76) 2014; 54 M Rausa (415_CR225) 2016; 17 Z Katsarava (415_CR244) 2005; 25 AA Gelfand (415_CR248) 2014; 18 JA Pijpers (415_CR162) 2022; 29 K Paemeleire (415_CR229) 2010; 30 O Luvsannorov (415_CR16) 2019; 20 D Le Bars (415_CR124) 1992; 4 N Vandenbussche (415_CR41) 2018; 19 AI Scher (415_CR193) 2017; 89 D Rastenytė (415_CR21) 2017; 18 SD Siberstein (415_CR66) 1994; 34 GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (415_CR14) 2016; 388 K Zebenholzer (415_CR251) 2012; 28 W Supornsilpchai (415_CR148) 2010; 30 J Hoffmann (415_CR129) 2013; 17 DW Dodick (415_CR258) 2019; 381 D Saylor (415_CR51) 2018; 38 P Sarchielli (415_CR40) 2016; 23 VT Martin (415_CR104) 2006; 46 RB Lipton (415_CR176) 2021; 61 P Jonsson (415_CR35) 2011; 31 T Vos (415_CR59) 2015; 386 PK Eide (415_CR166) 2000; 4 RB Lipton (415_CR259) 2019; 381 T Steiner (415_CR62) 2014; 34 HW Schytz (415_CR208) 2021; 22 415_CR180 V Anttila (415_CR87) 2018; 360 GA Peters (415_CR1) 1951; 26 T Hedenrud (415_CR189) 2014; 54 IE Verhagen (415_CR103) 2022; 42 |
References_xml | – volume: 48 start-page: 1026 year: 2008 end-page: 1036 ident: CR91 article-title: Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria publication-title: Headache doi: 10.1111/j.1526-4610.2007.00999.x – volume: 24 start-page: 1289 year: 2014 end-page: 1297 ident: CR215 article-title: Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2014.03.010 – volume: 34 start-page: 409 year: 2014 end-page: 425 ident: CR2 article-title: Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review publication-title: Cephalalgia doi: 10.1177/0333102413512033 – volume: 115 start-page: 441 year: 2002 end-page: 453 ident: CR141 article-title: Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00452-9 – volume: 18 start-page: 28 year: 2017 ident: CR23 article-title: Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey publication-title: J. Headache Pain doi: 10.1186/s10194-017-0734-1 – volume: 61 start-page: 790 year: 2021 end-page: 791 ident: CR10 article-title: Medication-overuse headache in patients with secondary headache disorders: need for revision? publication-title: Headache doi: 10.1111/head.14108 – volume: 153 start-page: 682 year: 2012 end-page: 686 ident: CR92 article-title: Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache publication-title: Pain doi: 10.1016/j.pain.2011.12.008 – volume: 8 start-page: 56 year: 2007 end-page: 59 ident: CR101 article-title: Cephalalgiaphobia: a possible specific phobia of illness publication-title: J. Headache Pain doi: 10.1007/s10194-007-0361-3 – volume: 33 start-page: 202 year: 2013 end-page: 207 ident: CR211 article-title: Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study publication-title: Cephalalgia doi: 10.1177/0333102412462638 – volume: 53 start-page: 665 year: 2013 end-page: 672 ident: CR249 article-title: Reduction of medication costs after detoxification for medication-overuse headache publication-title: Headache doi: 10.1111/head.12031 – volume: 34 start-page: 645 year: 2014 end-page: 655 ident: CR207 article-title: A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study publication-title: Cephalalgia doi: 10.1177/0333102414521508 – volume: 46 start-page: 3 year: 2006 end-page: 23 ident: CR104 article-title: Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis–part I publication-title: Headache doi: 10.1111/j.1526-4610.2006.00309.x – volume: 21 start-page: 544 year: 2021 ident: CR100 article-title: Understanding the genetics and neurobiological pathways behind addiction (review) publication-title: Exp. Ther. Med. doi: 10.3892/etm.2021.9976 – volume: 15 year: 2014 ident: CR69 article-title: The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-5 – volume: 29 start-page: 1021 year: 2009 end-page: 1027 ident: CR218 article-title: Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01859.x – volume: 18 year: 2017 ident: CR21 article-title: Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project publication-title: J. Headache Pain doi: 10.1186/s10194-017-0759-5 – volume: 38 start-page: 182 year: 2018 end-page: 190 ident: CR51 article-title: The global burden of headache publication-title: Semin. Neurol. doi: 10.1055/s-0038-1646946 – volume: 58 start-page: 319 year: 2018 end-page: 321 ident: CR12 article-title: De-stigmatizing migraine - with words publication-title: Headache doi: 10.1111/head.13209 – volume: 24 start-page: 193 year: 2011 end-page: 196 ident: CR121 article-title: Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache publication-title: Curr. Opin. Neurol. doi: 10.1097/WCO.0b013e328346af25 – volume: 97 start-page: e1661 year: 2021 end-page: e1671 ident: CR107 article-title: Comparing perimenstrual and nonperimenstrual migraine attacks using an e-Diary publication-title: Neurology doi: 10.1212/WNL.0000000000012723 – ident: CR191 – volume: 54 start-page: 211 year: 2014 end-page: 217 ident: CR76 article-title: Clinical aspects of medication overuse headaches publication-title: Headache doi: 10.1111/head.12223 – volume: 18 year: 2017 ident: CR139 article-title: Calcitonin gene-related peptide and pain: a systematic review publication-title: J. Headache Pain doi: 10.1186/s10194-017-0741-2 – volume: 22 start-page: 1228 year: 2015 end-page: 1234 ident: CR52 article-title: Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China publication-title: Eur. J. Neurol. doi: 10.1111/ene.12732 – ident: CR57 – volume: 4 start-page: 55 year: 1992 end-page: 65 ident: CR124 article-title: Diffuse noxious inhibitory controls (DNIC) in animals and in man publication-title: Patol. Fiziol. Eksp. Ter. – volume: 88 start-page: 1250 year: 2017 end-page: 1255 ident: CR238 article-title: Nonpainful remote electrical stimulation alleviates episodic migraine pain publication-title: Neurology doi: 10.1212/WNL.0000000000003760 – volume: 22 start-page: 1356 year: 2007 end-page: 1359 ident: CR43 article-title: Emotional problems and prevalence of medication overuse in pediatric chronic daily headache publication-title: J. Child Neurol. doi: 10.1177/0883073807307090 – volume: 40 start-page: 1202 year: 2020 end-page: 1211 ident: CR230 article-title: No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: a double blind, randomised clinical trial publication-title: Cephalalgia doi: 10.1177/0333102420931050 – volume: 38 start-page: 1 year: 2018 end-page: 211 ident: CR4 article-title: The International Classification of Headache Disorders, 3rd edition publication-title: Cephalalgia doi: 10.1177/0333102417738202 – volume: 17 year: 2016 ident: CR37 article-title: Headache, depression and anxiety: associations in the Eurolight project publication-title: J. Headache Pain doi: 10.1186/s10194-016-0649-2 – volume: 14 year: 2013 ident: CR90 article-title: Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study publication-title: J. Headache Pain doi: 10.1186/1129-2377-14-59 – volume: 77 start-page: 1069 year: 2020 end-page: 1078 ident: CR164 article-title: Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2020.1179 – volume: 96 start-page: 162 year: 2021 end-page: 170 ident: CR108 article-title: Sex differences in response to triptans: a systematic review and meta-analysis publication-title: Neurology doi: 10.1212/WNL.0000000000011216 – volume: 31 start-page: 851 year: 2011 end-page: 860 ident: CR131 article-title: Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies publication-title: Cephalalgia doi: 10.1177/0333102411402367 – volume: 61 start-page: 125 year: 2021 end-page: 136 ident: CR170 article-title: Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: subgroup analysis of PROMISE-2 publication-title: Headache doi: 10.1111/head.14036 – volume: 17 year: 2013 ident: CR129 article-title: Migraine and triggers: post hoc ergo propter hoc publication-title: Curr. Pain Headache Rep doi: 10.1007/s11916-013-0370-7 – volume: 30 start-page: 1101 year: 2010 end-page: 1109 ident: CR148 article-title: Cortical hyperexcitability and mechanism of medication-overuse headache publication-title: Cephalalgia doi: 10.1177/0333102409355600 – volume: 99 start-page: 529 year: 2000 end-page: 539 ident: CR142 article-title: Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00226-8 – volume: 36 start-page: 1324 year: 2016 end-page: 1333 ident: CR111 article-title: Gray matter changes related to medication overuse in patients with chronic migraine publication-title: Cephalalgia doi: 10.1177/0333102416630593 – volume: 17 start-page: 110 year: 2016 ident: CR25 article-title: The prevalence of primary headache disorders in Ethiopia publication-title: J. Headache Pain doi: 10.1186/s10194-016-0704-z – volume: 59 start-page: 306 year: 2019 end-page: 338 ident: CR8 article-title: Migraine progression: a systematic review publication-title: Headache doi: 10.1111/head.13459 – volume: 94 start-page: 1793 issue: (Suppl. 15) year: 2020 ident: CR173 article-title: Rimegepant 75 mg results in reductions in monthly migraine days: secondary analysis of a multicenter, open label long-term safety study of rimegepant for the acute treatment of migraine publication-title: Neurology – volume: 55 start-page: 128 year: 2015 end-page: 135 ident: CR213 article-title: Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial publication-title: Headache doi: 10.1111/head.12487 – volume: 89 start-page: 107 year: 2001 end-page: 110 ident: CR120 article-title: Deconstructing migraine headache into peripheral and central sensitization publication-title: Pain doi: 10.1016/S0304-3959(00)00478-4 – volume: 49 start-page: 413 year: 1987 end-page: 435 ident: CR82 article-title: Functions of angiotensin in the central nervous system publication-title: Annu. Rev. Physiol. doi: 10.1146/annurev.ph.49.030187.002213 – volume: 49 start-page: 412 year: 2009 end-page: 418 ident: CR96 article-title: Family history for chronic headache and drug overuse as a risk factor for headache chronification publication-title: Headache doi: 10.1111/j.1526-4610.2008.01257.x – volume: 23 year: 2022 ident: CR75 article-title: Applying a biopsychosocial model to migraine: rationale and clinical implications publication-title: J. Headache Pain doi: 10.1186/s10194-022-01471-3 – volume: 61 start-page: 1021 year: 2021 end-page: 1039 ident: CR174 article-title: The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice publication-title: Headache doi: 10.1111/head.14153 – volume: 6 start-page: 81 year: 2010 end-page: 91 ident: CR44 article-title: Psychiatric comorbidity and suicide risk in patients with chronic migraine publication-title: Neuropsychiatr. Dis. Treat. doi: 10.2147/NDT.S8467 – volume: 39 start-page: 135 year: 2018 end-page: 147 ident: CR45 article-title: Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: a six-month follow-up of the COMOESTAS Project publication-title: Cephalalgia doi: 10.1177/0333102418783317 – volume: 360 start-page: eaap8757 year: 2018 ident: CR87 article-title: Analysis of shared heritability in common disorders of the brain publication-title: Science doi: 10.1126/science.aap8757 – volume: 38 start-page: 1316 year: 2018 end-page: 1325 ident: CR188 article-title: National awareness campaign to prevent medication-overuse headache in Denmark publication-title: Cephalalgia doi: 10.1177/0333102417736898 – volume: 20 year: 2019 ident: CR16 article-title: Primary headache disorders among the adult population of Mongolia: prevalences and associations from a population-based survey publication-title: J. Headache Pain doi: 10.1186/s10194-019-1061-5 – volume: 34 start-page: 1 year: 1994 end-page: 7 ident: CR66 article-title: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria publication-title: Headache doi: 10.1111/j.1526-4610.1994.hed3401001.x – volume: 13 start-page: 346 year: 2019 end-page: 353 ident: CR89 article-title: Severity of analgesic dependence and medication-overuse headache publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000504 – volume: 10 year: 2010 ident: CR152 article-title: Abnormal cortical responses to somatosensory stimulation in medication-overuse headache publication-title: BMC Neurol. doi: 10.1186/1471-2377-10-126 – volume: 22 year: 2018 ident: CR128 article-title: Triggers, protectors, and predictors in episodic migraine publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-018-0734-0 – volume: 28 start-page: 61 year: 1988 end-page: 62 ident: CR73 article-title: Does analgesic abuse cause headaches de novo? publication-title: Headache doi: 10.1111/j.1526-4610.1988.hed2801060_2.x – volume: 10 start-page: 1336 year: 2020 end-page: 1336 ident: CR113 article-title: Brain structural and functional imaging findings in medication-overuse headache publication-title: Front. Neurol. doi: 10.3389/fneur.2019.01336 – volume: 59 start-page: 1011 year: 2002 end-page: 1014 ident: CR175 article-title: Features of medication overuse headache following overuse of different acute headache drugs publication-title: Neurology doi: 10.1212/WNL.59.7.1011 – volume: 40 start-page: 3 year: 2020 end-page: 5 ident: CR61 article-title: Medication overuse headache: the trouble with prevalence estimates publication-title: Cephalalgia doi: 10.1177/0333102419876907 – volume: 3 start-page: S550 year: 2003 end-page: S555 ident: CR185 article-title: Clinical clues and clinical rules: primary vs secondary headache publication-title: Adv. Stud. Med. – volume: 153 start-page: 56 year: 2012 end-page: 61 ident: CR9 article-title: Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies publication-title: Pain doi: 10.1016/j.pain.2011.08.018 – volume: 397 start-page: 51 year: 2021 end-page: 60 ident: CR220 article-title: Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(20)32544-7 – volume: 39 start-page: 274 year: 2019 end-page: 285 ident: CR183 article-title: Economic benefits of treating medication-overuse headache–results from the multicenter COMOESTAS project publication-title: Cephalalgia doi: 10.1177/0333102418786265 – volume: 29 start-page: 93 year: 2008 end-page: 98 ident: CR243 article-title: Headache with medication overuse: treatment strategies and proposals of relapse prevention publication-title: Neurol. Sci. doi: 10.1007/s10072-008-0867-8 – volume: 42 start-page: 1184 year: 2022 end-page: 1193 ident: CR103 article-title: Validation of diagnostic ICHD-3 criteria for menstrual migraine publication-title: Cephalalgia doi: 10.1177/03331024221099031 – volume: 16 start-page: 73 year: 2012 end-page: 79 ident: CR93 article-title: Dependent behavior in patients with medication-overuse headache publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-011-0240-0 – volume: 381 start-page: 2230 year: 2019 end-page: 2241 ident: CR258 article-title: Ubrogepant for the treatment of migraine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1813049 – volume: 15 start-page: 86 year: 2014 ident: CR32 article-title: The global burden of headache in children and adolescents-developing a questionnaire and methodology for a global study publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-86 – volume: 89 start-page: 461 year: 2017 end-page: 468 ident: CR193 article-title: Comorbid pain and migraine chronicity: the chronic migraine epidemiology and outcomes study publication-title: Neurology doi: 10.1212/WNL.0000000000004177 – volume: 57 start-page: 1173 year: 2017 end-page: 1178 ident: CR110 article-title: Medication overuse headache: pathophysiological insights from structural and functional brain MRI research publication-title: Headache doi: 10.1111/head.13037 – volume: 36 start-page: 371 year: 2016 end-page: 386 ident: CR202 article-title: Treatment of medication-overuse headache: a systematic review publication-title: Cephalalgia doi: 10.1177/0333102415593088 – volume: 34 start-page: 403 year: 2014 end-page: 404 ident: CR62 article-title: Can we know the prevalence of MOH? publication-title: Cephalalgia doi: 10.1177/0333102414520768 – volume: 34 start-page: 594 year: 2014 end-page: 604 ident: CR149 article-title: Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache publication-title: Cephalalgia doi: 10.1177/0333102413515344 – volume: 381 start-page: 142 year: 2019 end-page: 149 ident: CR259 article-title: Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1811090 – volume: 262 start-page: 692 year: 1992 end-page: 698 ident: CR158 article-title: Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/−)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin publication-title: J. Pharmacol. Exp. Ther. – volume: 142 start-page: 1203 year: 2019 end-page: 1214 ident: CR163 article-title: Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial publication-title: Brain doi: 10.1093/brain/awz052 – volume: 26 start-page: 1097 year: 2006 end-page: 1105 ident: CR199 article-title: Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2006.01175.x – volume: 24 start-page: 9 year: 2004 end-page: 160 ident: CR65 article-title: The International Classification of Headache Disorders: 2nd edition publication-title: Cephalalgia – volume: 26 start-page: 1202 year: 2018 end-page: 1216 ident: CR86 article-title: Molecular genetic overlap between migraine and major depressive disorder publication-title: Eur. J. Hum. Genet. doi: 10.1038/s41431-018-0150-2 – volume: 21 year: 2020 ident: CR22 article-title: The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study publication-title: J. Headache Pain doi: 10.1186/s10194-020-1081-1 – volume: 48 start-page: 1157 year: 2008 end-page: 1168 ident: CR6 article-title: Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study publication-title: Headache doi: 10.1111/j.1526-4610.2008.01217.x – volume: 47 start-page: 170 year: 2007 end-page: 180 ident: CR217 article-title: Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial publication-title: Headache doi: 10.1111/j.1526-4610.2006.00684.x – volume: 43 start-page: 635 year: 2020 end-page: 648 ident: CR106 article-title: An emerging role for prolactin in female-selective pain publication-title: Trends Neurosci. doi: 10.1016/j.tins.2020.06.003 – volume: 115 start-page: 208 year: 2016 end-page: 217 ident: CR150 article-title: Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas publication-title: J. Neurophysiol. doi: 10.1152/jn.00632.2015 – volume: 29 start-page: 1496 year: 2022 end-page: 1504 ident: CR162 article-title: Behavioural intervention in medication overuse headache: a concealed double-blind randomized controlled trial publication-title: Eur. J. Neurol. doi: 10.1111/ene.15256 – volume: 9 start-page: 373 year: 2010 end-page: 380 ident: CR235 article-title: Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(10)70054-5 – ident: CR15 – volume: 21 year: 2020 ident: CR27 article-title: The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study publication-title: J. Headache Pain doi: 10.1186/s10194-020-01179-2 – volume: 19 year: 2018 ident: CR41 article-title: Medication-overuse headache: a widely recognized entity amidst ongoing debate publication-title: J. Headache Pain doi: 10.1186/s10194-018-0875-x – volume: 51 start-page: 9 year: 2015 end-page: 16 ident: CR143 article-title: Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model publication-title: Neuropeptides doi: 10.1016/j.npep.2015.03.008 – volume: 58 start-page: 109 year: 2018 end-page: 117 ident: CR190 article-title: Headache education active-waiting directive: a program to enhance well-being during long referral wait times publication-title: Headache doi: 10.1111/head.13194 – volume: 69 start-page: 26 year: 2007 end-page: 31 ident: CR210 article-title: Prednisolone does not reduce withdrawal headache: a randomized, double-blind study publication-title: Neurology doi: 10.1212/01.wnl.0000263652.46222.e8 – volume: 37 start-page: 251 year: 2017 end-page: 264 ident: CR154 article-title: Serotonergic mechanisms in the migraine brain - a systematic review publication-title: Cephalalgia doi: 10.1177/0333102416640501 – volume: 8 start-page: 1 year: 1988 end-page: 96 ident: CR3 article-title: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain publication-title: Cephalalgia – volume: 19 start-page: 38 year: 2018 ident: CR5 article-title: Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study publication-title: J. Headache Pain doi: 10.1186/s10194-018-0865-z – volume: 22 year: 2021 ident: CR42 article-title: Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study publication-title: J. Headache Pain doi: 10.1186/s10194-021-01248-0 – volume: 14 year: 2013 ident: CR160 article-title: Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial publication-title: J. Headache Pain doi: 10.1186/1129-2377-14-10 – volume: 34 start-page: 426 year: 2014 end-page: 433 ident: CR38 article-title: Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) publication-title: Cephalalgia doi: 10.1177/0333102413515338 – volume: 33 start-page: 444 year: 2013 end-page: 453 ident: CR134 article-title: Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study publication-title: Cephalalgia doi: 10.1177/0333102412475235 – volume: 21 year: 2020 ident: CR168 article-title: The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study publication-title: J. Headache Pain doi: 10.1186/s10194-020-01173-8 – volume: 15 year: 2014 ident: CR187 article-title: Should we educate about the risks of medication overuse headache publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-10 – volume: 25 start-page: 12 year: 2005 end-page: 15 ident: CR244 article-title: Medication overuse headache: rates and predictors for relapse in a 4-year prospective study publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2004.00789.x – volume: 15 start-page: 3 year: 2014 ident: CR70 article-title: Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-3 – volume: 30 start-page: S89 year: 2009 end-page: S93 ident: CR222 article-title: Non-pharmacological approaches to treating chronic migraine with medication overuse publication-title: Neurol. Sci. doi: 10.1007/s10072-009-0081-3 – volume: 39 start-page: 617 year: 2019 end-page: 625 ident: CR130 article-title: Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: relevance to medication overuse headache publication-title: Cephalalgia doi: 10.1177/0333102418804157 – volume: 50 start-page: 464 year: 2014 end-page: 468 ident: CR179 article-title: Does analgesic overuse contribute to chronic post-traumatic headaches in adolescent concussion patients? publication-title: Pediatr. Neurol. doi: 10.1016/j.pediatrneurol.2014.01.040 – volume: 4 start-page: 5 year: 2000 end-page: 15 ident: CR166 article-title: Wind-up and the NMDA receptor complex from a clinical perspective publication-title: Eur. J. Pain doi: 10.1053/eujp.1999.0154 – volume: 57 start-page: 1065 year: 2017 end-page: 1087 ident: CR234 article-title: Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial publication-title: Headache doi: 10.1111/head.13120 – volume: 129 start-page: 543 year: 2006 end-page: 550 ident: CR114 article-title: Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine publication-title: Brain doi: 10.1093/brain/awh691 – volume: 38 start-page: 265 year: 2018 end-page: 273 ident: CR241 article-title: Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: a prospective cohort study publication-title: Cephalalgia doi: 10.1177/0333102416683918 – volume: 40 start-page: 503 year: 2019 end-page: 516 ident: CR118 article-title: Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies publication-title: Cephalalgia doi: 10.1177/0333102419883355 – volume: 12 start-page: 315 year: 2011 end-page: 322 ident: CR252 article-title: A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study publication-title: J. Headache Pain doi: 10.1007/s10194-010-0285-1 – volume: 62 start-page: 1540 year: 2004 end-page: 1544 ident: CR11 article-title: Analgesic overuse among subjects with headache, neck, and low-back pain publication-title: Neurology doi: 10.1212/01.WNL.0000123262.96132.FC – volume: 23 year: 2019 ident: CR197 article-title: Medication overuse and medication overuse headache: risk factors, comorbidities, associated burdens and nonpharmacologic and pharmacologic treatment approaches publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-019-0796-7 – volume: 17 year: 2016 ident: CR225 article-title: Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial publication-title: J. Headache Pain doi: 10.1186/s10194-016-0679-9 – volume: 41 start-page: 1161 year: 2021 end-page: 1171 ident: CR186 article-title: E-diary use in clinical headache practice: a prospective observational study publication-title: Cephalalgia doi: 10.1177/03331024211010306 – volume: 27 start-page: 814 year: 2007 end-page: 823 ident: CR214 article-title: Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2007.01326.x – volume: 385 start-page: 695 year: 2021 end-page: 706 ident: CR257 article-title: Atogepant for the preventive treatment of migraine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2035908 – volume: 59 start-page: 1481 year: 2019 end-page: 1491 ident: CR48 article-title: Clinical subtypes of medication overuse headache - findings from a large cohort publication-title: Headache doi: 10.1111/head.13641 – volume: 52 start-page: 1350 year: 2012 end-page: 1361 ident: CR137 article-title: Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment publication-title: Headache doi: 10.1111/j.1526-4610.2012.02170.x – volume: 119 start-page: 99 year: 2009 end-page: 109 ident: CR159 article-title: Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1 publication-title: J. Clin. Invest. – volume: 92 start-page: 134 year: 2019 end-page: 144 ident: CR184 article-title: Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list publication-title: Neurology doi: 10.1212/WNL.0000000000006697 – volume: 31 start-page: 1015 year: 2011 end-page: 1022 ident: CR35 article-title: Epidemiology of medication overuse headache in the general Swedish population publication-title: Cephalalgia doi: 10.1177/0333102411410082 – volume: 35 start-page: 545 year: 2021 end-page: 565 ident: CR72 article-title: The evolution of medication overuse headache: history, pathophysiology and clinical update publication-title: CNS Drugs doi: 10.1007/s40263-021-00818-9 – volume: 43 start-page: 179 year: 2003 end-page: 190 ident: CR74 article-title: Does chronic daily headache arise de novo in association with regular use of analgesics? publication-title: Headache doi: 10.1046/j.1526-4610.2003.03041.x – volume: 12 start-page: 42 year: 2018 ident: CR105 article-title: Pituitary hormones and orofacial pain publication-title: Front. Integr. Neurosci. doi: 10.3389/fnint.2018.00042 – volume: 383 start-page: 1866 year: 2020 end-page: 1876 ident: CR119 article-title: Migraine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1915327 – volume: 22 year: 2021 ident: CR208 article-title: Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020 publication-title: J. Headache Pain doi: 10.1186/s10194-021-01228-4 – volume: 18 start-page: 891 year: 2019 end-page: 902 ident: CR71 article-title: Pathophysiology, prevention, and treatment of medication overuse headache publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(19)30146-2 – volume: 41 start-page: 643 year: 2021 end-page: 648 ident: CR102 article-title: Sex differences in prevalence of migraine trigger factors: a cross-sectional study publication-title: Cephalalgia doi: 10.1177/0333102420974362 – volume: 42 start-page: 197 year: 2022 end-page: 208 ident: CR132 article-title: A prolactin-dependent sexually dimorphic mechanism of migraine chronification publication-title: Cephalalgia doi: 10.1177/03331024211039813 – volume: 19 start-page: 14116 year: 2022 ident: CR226 article-title: A preliminary analysis on the feasibility and short-term efficacy of a phase-III RCT on mindfulness added to treatment as usual for patients with chronic migraine and medication overuse headache publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph192114116 – volume: 22 start-page: 37 year: 1980 end-page: 50 ident: CR85 article-title: Neuropeptides and central catecholamine systems: interactions in neuroendocrine and central cardiovascular regulation publication-title: Adv. Biochem. Psychopharmacol. – year: 2022 ident: CR115 article-title: Medication overuse headache associated with decreased dopamine transporter availability in the medial but not in the lateral orbitofrontal cortex: a (11)CFT PET/MR study publication-title: Int. J. Neurosci. doi: 10.1080/00207454.2022.2126773 – volume: 16 year: 2015 ident: CR24 article-title: The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey publication-title: J. Headache Pain – volume: 42 start-page: 560 year: 2022 end-page: 569 ident: CR233 article-title: Non-invasive vagus nerve stimulation for prevention of migraine: the multicenter, randomized, double-blind, sham-controlled PREMIUM II trial publication-title: Cephalalgia doi: 10.1177/03331024211068813 – volume: 61 start-page: 351 year: 2021 end-page: 362 ident: CR49 article-title: Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial publication-title: Headache doi: 10.1111/head.14056 – volume: 21 start-page: 878 year: 2001 end-page: 883 ident: CR245 article-title: Long-term follow-up of patients treated for chronic headache with analgesic overuse publication-title: Cephalalgia doi: 10.1046/j.1468-2982.2001.00288.x – volume: 67 start-page: 325 year: 2010 end-page: 337 ident: CR145 article-title: Triptan-induced latent sensitization: a possible basis for medication overuse headache publication-title: Ann. Neurol. – volume: 40 start-page: 903 year: 2020 end-page: 912 ident: CR260 article-title: Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache publication-title: Cephalalgia doi: 10.1177/0333102420920006 – volume: 386 start-page: 743 year: 2015 end-page: 800 ident: CR59 article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 publication-title: Lancet doi: 10.1016/S0140-6736(15)60692-4 – volume: 86 start-page: 505 year: 2015 end-page: 512 ident: CR200 article-title: Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2014-308548 – volume: 13 start-page: 255 year: 2012 end-page: 262 ident: CR117 article-title: Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study publication-title: Pain Med. doi: 10.1111/j.1526-4637.2011.01183.x – volume: 41 start-page: 1053 year: 2021 end-page: 1064 ident: CR46 article-title: Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: results from the MOTS trial publication-title: Cephalalgia doi: 10.1177/03331024211006903 – volume: 17 start-page: 107 year: 2016 ident: CR182 article-title: Risk of medication overuse headache across classes of treatments for acute migraine publication-title: J. Headache Pain doi: 10.1186/s10194-016-0696-8 – volume: 29 start-page: 221 year: 2009 end-page: 232 ident: CR201 article-title: Management of medication overuse headache: 1-year randomized multicentre open-label trial publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2008.01711.x – volume: 68 start-page: 1468 year: 2007 end-page: 1473 ident: CR50 article-title: Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache publication-title: Neurology doi: 10.1212/01.wnl.0000260607.90634.d6 – volume: 331 start-page: 48 year: 2013 end-page: 56 ident: CR216 article-title: OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2013.05.003 – volume: 18 year: 2014 ident: CR248 article-title: Medication overuse in children and adolescents publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-014-0428-1 – volume: 155 start-page: 2005 year: 2014 end-page: 2013 ident: CR33 article-title: Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status publication-title: Pain doi: 10.1016/j.pain.2014.07.002 – volume: 51 start-page: 197 year: 2021 end-page: 208 ident: CR125 article-title: Conditioned pain modulation — a comprehensive review publication-title: Neurophysiol. Clin. doi: 10.1016/j.neucli.2020.11.002 – volume: 40 start-page: 343 year: 2000 end-page: 350 ident: CR155 article-title: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache publication-title: Headache doi: 10.1046/j.1526-4610.2000.00052.x – volume: 27 start-page: 1102 year: 2020 end-page: 1116 ident: CR198 article-title: European Academy of Neurology guideline on the management of medication-overuse headache publication-title: Eur. J. Neurol. doi: 10.1111/ene.14268 – volume: 25 start-page: 460 year: 2005 end-page: 465 ident: CR64 article-title: The International Classification of Headache Disorders, 2nd edition (ICHD-II)–revision of criteria for 8.2 Medication-overuse headache publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2005.00878.x – volume: 23 start-page: 118 year: 2022 ident: CR31 article-title: The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study publication-title: J. Headache Pain doi: 10.1186/s10194-022-01477-x – volume: 19 start-page: 2575 year: 2018 end-page: 2577 ident: CR240 article-title: Noninvasive vagal nerve stimulation in chronic migraine with medication overuse headache publication-title: Pain Med. doi: 10.1093/pm/pny084 – volume: 23 start-page: 982 year: 2003 end-page: 993 ident: CR209 article-title: Out-patient detoxification in chronic migraine: comparison of strategies publication-title: Cephalalgia doi: 10.1046/j.1468-2982.2003.00648.x – volume: 32 start-page: 834 year: 2012 end-page: 844 ident: CR224 article-title: Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design publication-title: Cephalalgia doi: 10.1177/0333102412451363 – volume: 54 start-page: 152 year: 2022 end-page: 160 ident: CR77 article-title: Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles publication-title: Nat. Genet. doi: 10.1038/s41588-021-00990-0 – volume: 38 start-page: 1361 year: 2018 end-page: 1373 ident: CR81 article-title: A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache publication-title: Cephalalgia doi: 10.1177/0333102417728244 – volume: 30 start-page: 272 year: 2010 end-page: 284 ident: CR138 article-title: Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01914.x – volume: 33 start-page: 132 year: 2021 end-page: 143 ident: CR250 article-title: Depression, anxiety, stress, and health-related quality of life among patients with medication overuse headache in a tertiary headache center: a cross-sectional study publication-title: J. Neuropsychiatry Clin. Neurosci. doi: 10.1176/appi.neuropsych.20070189 – volume: 25 start-page: 545 year: 2005 end-page: 546 ident: CR95 article-title: Medication overuse headache (MOH) is a biobehavioural disorder publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2005.00879.x – volume: 5 start-page: 987 year: 2018 end-page: 1012 ident: CR99 article-title: The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(18)30337-7 – volume: 21 year: 2020 ident: CR30 article-title: The prevalence of headache disorders in children and adolescents in Mongolia: a nationwide schools-based study publication-title: J. Headache Pain doi: 10.1186/s10194-020-01175-6 – volume: 54 start-page: 1019 year: 2014 end-page: 1025 ident: CR189 article-title: Medication overuse headache: self-perceived and actual knowledge among pharmacy staff publication-title: Headache doi: 10.1111/head.12350 – volume: 52 start-page: 582 year: 2012 end-page: 591 ident: CR17 article-title: The prevalence and burden of primary headaches in China: a population-based door-to-door survey publication-title: Headache doi: 10.1111/j.1526-4610.2011.02061.x – volume: 32 start-page: 373 year: 2012 end-page: 381 ident: CR20 article-title: The prevalence of primary headache disorders in Russia: a countrywide survey publication-title: Cephalalgia doi: 10.1177/0333102412438977 – volume: 37 start-page: 780 year: 2017 end-page: 794 ident: CR126 article-title: Kappa opioid receptor antagonists: a possible new class of therapeutics for migraine prevention publication-title: Cephalalgia doi: 10.1177/0333102417702120 – volume: 13 start-page: 399 year: 2009 end-page: 403 ident: CR109 article-title: Migraine headache in perimenopausal and menopausal women publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-009-0065-2 – volume: 21 start-page: 989 year: 2014 end-page: 995 ident: CR80 article-title: Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy publication-title: Eur. J. Neurol. doi: 10.1111/ene.12424 – volume: 61 start-page: 103 year: 2021 end-page: 116 ident: CR176 article-title: Burden of increasing opioid use in the treatment of migraine: results from the Migraine in America Symptoms and Treatment study publication-title: Headache doi: 10.1111/head.14018 – volume: 103 start-page: 1 year: 1995 end-page: 44 ident: CR157 article-title: Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat publication-title: Acta Anaesthesiol. Scand. Suppl. – volume: 91 start-page: e364 year: 2018 end-page: e373 ident: CR237 article-title: Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study publication-title: Neurology doi: 10.1212/WNL.0000000000005857 – volume: 40 start-page: 6 year: 2020 end-page: 18 ident: CR34 article-title: Monitoring chronic headache and medication-overuse headache prevalence in Denmark publication-title: Cephalalgia doi: 10.1177/0333102419876909 – volume: 11 start-page: 226 year: 2020 ident: CR239 article-title: Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study publication-title: Front. Neurol. doi: 10.3389/fneur.2020.00226 – volume: 13 start-page: 517 year: 2012 end-page: 525 ident: CR112 article-title: Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety publication-title: World J. Biol. Psychiatry doi: 10.3109/15622975.2012.665175 – ident: CR13 – volume: 10 start-page: 349 year: 2009 end-page: 355 ident: CR79 article-title: Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism publication-title: J. Headache Pain doi: 10.1007/s10194-009-0136-0 – volume: 40 start-page: 892 year: 2020 end-page: 902 ident: CR171 article-title: Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache publication-title: Cephalalgia doi: 10.1177/0333102420938652 – volume: 38 start-page: 1038 year: 2018 end-page: 1048 ident: CR236 article-title: A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE study) publication-title: Cephalalgia doi: 10.1177/0333102418762525 – volume: 22 year: 2022 ident: CR53 article-title: Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study publication-title: BMC Geriatrics doi: 10.1186/s12877-022-03027-1 – volume: 24 start-page: 483 year: 2004 end-page: 490 ident: CR7 article-title: Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2004.00691.x – volume: 19 start-page: 703 year: 2012 end-page: 711 ident: CR60 article-title: The cost of headache disorders in Europe: the Eurolight project publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2011.03612.x – volume: 23 start-page: 28 year: 2016 end-page: 35 ident: CR39 article-title: Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study publication-title: Eur. J. Neurol. doi: 10.1111/ene.12850 – ident: CR83 – volume: 18 year: 2017 ident: CR212 article-title: Treatment of withdrawal headache in patients with medication overuse headache: a pilot study publication-title: J. Headache Pain doi: 10.1186/s10194-017-0763-9 – volume: 30 start-page: 329 year: 2010 end-page: 336 ident: CR246 article-title: Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol) publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01934.x – volume: 273 start-page: 887 year: 1995 end-page: 894 ident: CR144 article-title: Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites publication-title: J. Pharmacol. Exp. Ther. – volume: 31 start-page: 1510 year: 2011 end-page: 1521 ident: CR227 article-title: Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial publication-title: Cephalalgia doi: 10.1177/0333102411420585 – volume: 135 start-page: 376 year: 2012 end-page: 390 ident: CR133 article-title: The ‘headache tree’ via umbellulone and TRPA1 activates the trigeminovascular system publication-title: Brain doi: 10.1093/brain/awr272 – volume: 10 start-page: 173 year: 2019 ident: CR206 article-title: Negative short-term outcome of detoxification therapy in chronic migraine with medication overuse headache: role for early life traumatic experiences and recent stressful events publication-title: Front. Neurol. doi: 10.3389/fneur.2019.00173 – volume: 16 start-page: 67 year: 2015 ident: CR19 article-title: Headache disorders and public ill-health in India: prevalence estimates in Karnataka State publication-title: J. Headache Pain doi: 10.1186/s10194-015-0549-x – volume: 280 start-page: 934 year: 1997 end-page: 940 ident: CR156 article-title: Naloxone-reversible antinociception by paracetamol in the rat publication-title: J. Pharmacol. Exp. Ther. – volume: 81 start-page: 1261 year: 2010 end-page: 1264 ident: CR177 article-title: Medication overuse as a cause of chronic headache in shunted hydrocephalus patients publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.2009.198101 – volume: 30 start-page: 662 year: 2010 end-page: 673 ident: CR229 article-title: Phenotype of patients responsive to occipital nerve stimulation for refractory head pain publication-title: Cephalalgia – volume: 18 start-page: 329 year: 1980 end-page: 332 ident: CR84 article-title: Influence of angiotensin II on dog pineal serotonin content publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(80)90306-7 – volume: 40 start-page: 1717 year: 2019 end-page: 1724 ident: CR97 article-title: Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine publication-title: Neurol. Sci. doi: 10.1007/s10072-019-03865-9 – volume: 52 start-page: 233 year: 2015 end-page: 239 ident: CR253 article-title: Correlation between life events and quality of life in patients with medication-overuse headache publication-title: Noro Psikiyatr. Ars. doi: 10.5152/npa.2015.8799 – volume: 36 start-page: 15 year: 2016 end-page: 28 ident: CR55 article-title: Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey publication-title: Cephalalgia doi: 10.1177/0333102415578430 – volume: 26 start-page: 1106 year: 2006 end-page: 1114 ident: CR151 article-title: Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2006.01183.x – volume: 16 year: 2015 ident: CR18 article-title: The prevalence of primary headache disorders in Nepal: a nationwide population-based study publication-title: J. Headache Pain doi: 10.1186/s10194-015-0580-y – volume: 26 start-page: 153 year: 1951 end-page: 161 ident: CR1 article-title: Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects publication-title: Proc. Staff. Meet. Mayo Clin. – volume: 89 start-page: 1296 year: 2017 end-page: 1304 ident: CR196 article-title: Medication overuse headache: an entrenched idea in need of scrutiny publication-title: Neurology doi: 10.1212/WNL.0000000000004371 – volume: 124 start-page: 197 year: 2009 end-page: 202 ident: CR58 article-title: Disability and disability-adjusted life years: not the same publication-title: Public Health Rep. doi: 10.1177/003335490912400206 – volume: 21 year: 2020 ident: CR29 article-title: The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study publication-title: J. Headache Pain doi: 10.1186/s10194-020-01146-x – ident: CR67 – volume: 22 year: 2021 ident: CR88 article-title: Medication overuse and drug addiction: a narrative review from addiction perspective publication-title: J. Headache Pain doi: 10.1186/s10194-021-01224-8 – volume: 52 start-page: 18 year: 2012 end-page: 36 ident: CR94 article-title: Opioid use and dependence among persons with migraine: results of the AMPP study publication-title: Headache doi: 10.1111/j.1526-4610.2011.02050.x – volume: 62 start-page: 890 year: 2022 end-page: 902 ident: CR181 article-title: Clinical characteristics of medication-overuse headache according to the class of acute medication: a cross-sectional multicenter study publication-title: Headache doi: 10.1111/head.14363 – volume: 42 start-page: 34 issue: Suppl. 1 year: 2022 end-page: 35 ident: CR219 article-title: Efficacy of oral atogepant in people with chronic migraine with and without acute medication overuse: results from the PROGRESS trial publication-title: Cephalalgia – volume: 50 start-page: 1464 year: 2010 end-page: 1472 ident: CR54 article-title: Increased prevalence of sleep disorders in chronic headache: a case–control study publication-title: Headache doi: 10.1111/j.1526-4610.2010.01711.x – volume: 106 start-page: 81 year: 2003 end-page: 89 ident: CR194 article-title: Factors associated with the onset and remission of chronic daily headache in a population-based study publication-title: Pain doi: 10.1016/S0304-3959(03)00293-8 – volume: 80 start-page: 697 year: 2013 end-page: 704 ident: CR232 article-title: Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial publication-title: Neurology doi: 10.1212/WNL.0b013e3182825055 – volume: 135 start-page: 426 year: 2017 end-page: 433 ident: CR221 article-title: Greater occipital nerve block in the treatment of triptan-overuse headache: a randomized comparative study publication-title: Acta Neurol. Scand. doi: 10.1111/ane.12692 – volume: 10 start-page: 895 year: 2009 end-page: 926 ident: CR122 article-title: Central sensitization: a generator of pain hypersensitivity by central neural plasticity publication-title: J. Pain doi: 10.1016/j.jpain.2009.06.012 – volume: 394 start-page: 737 year: 2019 end-page: 745 ident: CR172 article-title: Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(19)31606-X – volume: 22 start-page: 8312 year: 2002 end-page: 8323 ident: CR255 article-title: Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-18-08312.2002 – volume: 7 start-page: 24 year: 2021 ident: CR153 article-title: Tension-type headache publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-021-00257-2 – volume: 26 start-page: 62 year: 2005 end-page: 68 ident: CR147 article-title: Medication-overuse headache: similarities with drug addiction publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2004.12.008 – volume: 92 start-page: e2309 year: 2019 end-page: e2320 ident: CR169 article-title: Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial publication-title: Neurology doi: 10.1212/WNL.0000000000007497 – volume: 98 start-page: e1409 year: 2022 end-page: e1421 ident: CR203 article-title: Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized, pragmatic clinical trial publication-title: Neurology doi: 10.1212/WNL.0000000000200117 – volume: 133 start-page: 2475 year: 2010 end-page: 2488 ident: CR146 article-title: Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers publication-title: Brain doi: 10.1093/brain/awq159 – volume: 38 start-page: 225 year: 2018 end-page: 236 ident: CR204 article-title: Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial publication-title: Cephalalgia doi: 10.1177/0333102417737779 – volume: 120 start-page: 3779 year: 2010 end-page: 3787 ident: CR123 article-title: Central modulation of pain publication-title: J. Clin. Invest. doi: 10.1172/JCI43766 – volume: 41 start-page: 340 year: 2021 end-page: 352 ident: CR167 article-title: Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine publication-title: Cephalalgia doi: 10.1177/0333102420966658 – volume: 36 start-page: 122 year: 2016 end-page: 130 ident: CR223 article-title: Detoxification in medication-overuse headache, a retrospective controlled follow-up study: does care by a headache nurse lead to cure publication-title: Cephalalgia doi: 10.1177/0333102415583146 – volume: 12 start-page: 303 year: 2011 end-page: 310 ident: CR136 article-title: Basal cutaneous pain threshold in headache patients publication-title: J. Headache Pain doi: 10.1007/s10194-011-0313-9 – volume: 185 start-page: 108456 year: 2021 ident: CR127 article-title: Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2021.108456 – volume: 28 start-page: 705 year: 2008 end-page: 713 ident: CR36 article-title: Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2008.01577.x – volume: 23 start-page: 85 year: 2016 end-page: 91 ident: CR40 article-title: Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study publication-title: Eur. J. Neurol. doi: 10.1111/ene.12794 – volume: 33 start-page: 629 year: 2013 end-page: 808 ident: CR63 article-title: The International Classification of Headache Disorders, 3rd edition (beta version) publication-title: Cephalalgia doi: 10.1177/0333102413485658 – volume: 37 start-page: 1215 year: 2017 end-page: 1221 ident: CR242 article-title: Chronic headache with medication overuse: long-term prognosis after withdrawal therapy publication-title: Cephalalgia doi: 10.1177/0333102416672493 – ident: CR56 – volume: 50 start-page: 998 year: 2010 end-page: 1004 ident: CR116 article-title: Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations publication-title: Headache doi: 10.1111/j.1526-4610.2010.01695.x – volume: 46 start-page: S88 year: 2006 end-page: S97 ident: CR98 article-title: Medication overuse headache: biobehavioral issues and solutions publication-title: Headache doi: 10.1111/j.1526-4610.2006.00560.x – volume: 12 start-page: 575 year: 2016 end-page: 583 ident: CR47 article-title: Medication-overuse headache: risk factors, pathophysiology and management publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2016.124 – ident: CR180 – volume: 29 start-page: 30 year: 2015 end-page: 34 ident: CR178 article-title: Medication overuse headache–an under-diagnosed problem in shunted idiopathic intracranial hypertension patients publication-title: Br. J. Neurosurg. doi: 10.3109/02688697.2014.950633 – volume: 54 start-page: 1251 year: 2014 end-page: 1257 ident: CR165 article-title: Medication overuse headache publication-title: Headache doi: 10.1111/head.12408 – volume: 30 start-page: 943 year: 2010 end-page: 952 ident: CR192 article-title: Headache characteristics and chronification of migraine and tension-type headache: a population-based study publication-title: Cephalalgia doi: 10.1177/0333102409357958 – volume: 96 year: 2017 ident: CR254 article-title: Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation: a cross-sectional pilot study publication-title: Medicine doi: 10.1097/MD.0000000000008493 – volume: 11 start-page: 216 year: 2021 end-page: 226 ident: CR256 article-title: Medication overuse and headache burden: results from the CaMEO study publication-title: Neurol. Clin. Pract. doi: 10.1212/CPJ.0000000000001037 – volume: 23 year: 2022 ident: CR68 article-title: The Global Campaign turns 18: a brief review of its activities and achievements publication-title: J. Headache Pain doi: 10.1186/s10194-022-01420-0 – volume: 31 start-page: 161 year: 2011 end-page: 171 ident: CR247 article-title: Genomic expression patterns in medication overuse headaches publication-title: Cephalalgia doi: 10.1177/0333102410373155 – volume: 23 year: 2022 ident: CR26 article-title: The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates publication-title: J. Headache Pain doi: 10.1186/s10194-022-01402-2 – volume: 23 start-page: 1162 year: 2019 end-page: 1170 ident: CR205 article-title: Complete withdrawal is the most feasible treatment for medication-overuse headache: a randomized controlled open-label trial publication-title: Eur. J. Pain doi: 10.1002/ejp.1383 – volume: 28 start-page: 284 year: 2012 end-page: 290 ident: CR251 article-title: Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study publication-title: Clin. J. Pain doi: 10.1097/AJP.0b013e3182321d35 – volume: 388 start-page: 1545 year: 2016 end-page: 1602 ident: CR14 article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet doi: 10.1016/S0140-6736(16)31678-6 – volume: 37 start-page: 1115 year: 2017 end-page: 1125 ident: CR161 article-title: The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: a controlled multicentre study publication-title: Cephalalgia doi: 10.1177/0333102416660549 – volume: 19 year: 2018 ident: CR140 article-title: The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system publication-title: J. Headache Pain doi: 10.1186/s10194-018-0848-0 – volume: 9 start-page: 295 year: 2008 end-page: 300 ident: CR135 article-title: Evidence of persistent central sensitization in chronic headaches: a multi-method study publication-title: J. Headache Pain doi: 10.1007/s10194-008-0061-7 – volume: 132 start-page: 126 year: 2021 end-page: 136 ident: CR231 article-title: Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: a pilot double-blind randomized sham-controlled trial publication-title: Clin. Neurophysiol. doi: 10.1016/j.clinph.2020.10.014 – volume: 15 start-page: 245 year: 2012 end-page: 253 ident: CR228 article-title: Occipital nerve stimulation for chronic migraine: a randomized trial publication-title: Pain Physician doi: 10.36076/ppj.2012/15/245 – volume: 32 start-page: 1189 year: 2012 end-page: 1197 ident: CR78 article-title: Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism publication-title: Cephalalgia doi: 10.1177/0333102412461890 – volume: 42 start-page: 1246 year: 2022 end-page: 1254 ident: CR28 article-title: The prevalence of headache disorders in children and adolescents in Iran: a schools-based study publication-title: Cephalalgia doi: 10.1177/03331024221103814 – volume: 11 start-page: 373 year: 2010 end-page: 377 ident: CR195 article-title: Medication overuse headache: a critical review of end points in recent follow-up studies publication-title: J. Headache Pain doi: 10.1007/s10194-010-0221-4 – volume: 38 start-page: 182 year: 2018 ident: 415_CR51 publication-title: Semin. Neurol. doi: 10.1055/s-0038-1646946 – volume: 19 year: 2018 ident: 415_CR41 publication-title: J. Headache Pain doi: 10.1186/s10194-018-0875-x – volume: 42 start-page: 1184 year: 2022 ident: 415_CR103 publication-title: Cephalalgia doi: 10.1177/03331024221099031 – volume: 120 start-page: 3779 year: 2010 ident: 415_CR123 publication-title: J. Clin. Invest. doi: 10.1172/JCI43766 – volume: 37 start-page: 251 year: 2017 ident: 415_CR154 publication-title: Cephalalgia doi: 10.1177/0333102416640501 – volume: 41 start-page: 1161 year: 2021 ident: 415_CR186 publication-title: Cephalalgia doi: 10.1177/03331024211010306 – volume: 25 start-page: 12 year: 2005 ident: 415_CR244 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2004.00789.x – volume: 22 start-page: 8312 year: 2002 ident: 415_CR255 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-18-08312.2002 – volume: 21 year: 2020 ident: 415_CR27 publication-title: J. Headache Pain doi: 10.1186/s10194-020-01179-2 – volume: 31 start-page: 1015 year: 2011 ident: 415_CR35 publication-title: Cephalalgia doi: 10.1177/0333102411410082 – volume: 10 start-page: 1336 year: 2020 ident: 415_CR113 publication-title: Front. Neurol. doi: 10.3389/fneur.2019.01336 – volume: 28 start-page: 61 year: 1988 ident: 415_CR73 publication-title: Headache doi: 10.1111/j.1526-4610.1988.hed2801060_2.x – volume: 19 start-page: 38 year: 2018 ident: 415_CR5 publication-title: J. Headache Pain doi: 10.1186/s10194-018-0865-z – volume: 103 start-page: 1 year: 1995 ident: 415_CR157 publication-title: Acta Anaesthesiol. Scand. Suppl. – volume: 40 start-page: 6 year: 2020 ident: 415_CR34 publication-title: Cephalalgia doi: 10.1177/0333102419876909 – volume: 94 start-page: 1793 issue: (Suppl. 15) year: 2020 ident: 415_CR173 publication-title: Neurology doi: 10.1212/WNL.94.15_supplement.1793 – volume: 397 start-page: 51 year: 2021 ident: 415_CR220 publication-title: Lancet doi: 10.1016/S0140-6736(20)32544-7 – volume: 62 start-page: 1540 year: 2004 ident: 415_CR11 publication-title: Neurology doi: 10.1212/01.WNL.0000123262.96132.FC – volume: 34 start-page: 409 year: 2014 ident: 415_CR2 publication-title: Cephalalgia doi: 10.1177/0333102413512033 – volume: 273 start-page: 887 year: 1995 ident: 415_CR144 publication-title: J. Pharmacol. Exp. Ther. – volume: 30 start-page: 943 year: 2010 ident: 415_CR192 publication-title: Cephalalgia doi: 10.1177/0333102409357958 – volume: 33 start-page: 202 year: 2013 ident: 415_CR211 publication-title: Cephalalgia doi: 10.1177/0333102412462638 – volume: 15 start-page: 3 year: 2014 ident: 415_CR70 publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-3 – volume: 57 start-page: 1173 year: 2017 ident: 415_CR110 publication-title: Headache doi: 10.1111/head.13037 – volume: 23 start-page: 1162 year: 2019 ident: 415_CR205 publication-title: Eur. J. Pain doi: 10.1002/ejp.1383 – volume: 24 start-page: 1289 year: 2014 ident: 415_CR215 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2014.03.010 – volume: 49 start-page: 413 year: 1987 ident: 415_CR82 publication-title: Annu. Rev. Physiol. doi: 10.1146/annurev.ph.49.030187.002213 – volume: 17 year: 2013 ident: 415_CR129 publication-title: Curr. Pain Headache Rep doi: 10.1007/s11916-013-0370-7 – volume: 34 start-page: 403 year: 2014 ident: 415_CR62 publication-title: Cephalalgia doi: 10.1177/0333102414520768 – volume: 16 year: 2015 ident: 415_CR24 publication-title: J. Headache Pain – volume: 30 start-page: 272 year: 2010 ident: 415_CR138 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01914.x – volume: 96 start-page: 162 year: 2021 ident: 415_CR108 publication-title: Neurology doi: 10.1212/WNL.0000000000011216 – volume: 23 start-page: 118 year: 2022 ident: 415_CR31 publication-title: J. Headache Pain doi: 10.1186/s10194-022-01477-x – volume: 33 start-page: 629 year: 2013 ident: 415_CR63 publication-title: Cephalalgia doi: 10.1177/0333102413485658 – volume: 37 start-page: 780 year: 2017 ident: 415_CR126 publication-title: Cephalalgia doi: 10.1177/0333102417702120 – volume: 27 start-page: 814 year: 2007 ident: 415_CR214 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2007.01326.x – volume: 22 start-page: 1356 year: 2007 ident: 415_CR43 publication-title: J. Child Neurol. doi: 10.1177/0883073807307090 – volume: 52 start-page: 582 year: 2012 ident: 415_CR17 publication-title: Headache doi: 10.1111/j.1526-4610.2011.02061.x – volume: 11 start-page: 373 year: 2010 ident: 415_CR195 publication-title: J. Headache Pain doi: 10.1007/s10194-010-0221-4 – volume: 31 start-page: 1510 year: 2011 ident: 415_CR227 publication-title: Cephalalgia doi: 10.1177/0333102411420585 – volume: 106 start-page: 81 year: 2003 ident: 415_CR194 publication-title: Pain doi: 10.1016/S0304-3959(03)00293-8 – volume: 50 start-page: 998 year: 2010 ident: 415_CR116 publication-title: Headache doi: 10.1111/j.1526-4610.2010.01695.x – volume: 28 start-page: 705 year: 2008 ident: 415_CR36 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2008.01577.x – volume: 36 start-page: 15 year: 2016 ident: 415_CR55 publication-title: Cephalalgia doi: 10.1177/0333102415578430 – volume: 38 start-page: 265 year: 2018 ident: 415_CR241 publication-title: Cephalalgia doi: 10.1177/0333102416683918 – volume: 25 start-page: 545 year: 2005 ident: 415_CR95 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2005.00879.x – volume: 42 start-page: 34 issue: Suppl. 1 year: 2022 ident: 415_CR219 publication-title: Cephalalgia – volume: 26 start-page: 1106 year: 2006 ident: 415_CR151 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2006.01183.x – volume: 385 start-page: 695 year: 2021 ident: 415_CR257 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2035908 – volume: 3 start-page: S550 year: 2003 ident: 415_CR185 publication-title: Adv. Stud. Med. – volume: 23 year: 2022 ident: 415_CR68 publication-title: J. Headache Pain doi: 10.1186/s10194-022-01420-0 – volume: 381 start-page: 142 year: 2019 ident: 415_CR259 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1811090 – volume: 68 start-page: 1468 year: 2007 ident: 415_CR50 publication-title: Neurology doi: 10.1212/01.wnl.0000260607.90634.d6 – volume: 24 start-page: 193 year: 2011 ident: 415_CR121 publication-title: Curr. Opin. Neurol. doi: 10.1097/WCO.0b013e328346af25 – volume: 115 start-page: 441 year: 2002 ident: 415_CR141 publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00452-9 – volume: 13 start-page: 399 year: 2009 ident: 415_CR109 publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-009-0065-2 – volume: 89 start-page: 107 year: 2001 ident: 415_CR120 publication-title: Pain doi: 10.1016/S0304-3959(00)00478-4 – volume: 10 start-page: 895 year: 2009 ident: 415_CR122 publication-title: J. Pain doi: 10.1016/j.jpain.2009.06.012 – volume: 9 start-page: 373 year: 2010 ident: 415_CR235 publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(10)70054-5 – volume: 12 start-page: 303 year: 2011 ident: 415_CR136 publication-title: J. Headache Pain doi: 10.1007/s10194-011-0313-9 – volume: 155 start-page: 2005 year: 2014 ident: 415_CR33 publication-title: Pain doi: 10.1016/j.pain.2014.07.002 – ident: 415_CR15 – volume: 23 start-page: 28 year: 2016 ident: 415_CR39 publication-title: Eur. J. Neurol. doi: 10.1111/ene.12850 – volume: 22 year: 2021 ident: 415_CR208 publication-title: J. Headache Pain doi: 10.1186/s10194-021-01228-4 – volume: 38 start-page: 1361 year: 2018 ident: 415_CR81 publication-title: Cephalalgia doi: 10.1177/0333102417728244 – volume: 58 start-page: 319 year: 2018 ident: 415_CR12 publication-title: Headache doi: 10.1111/head.13209 – ident: 415_CR67 – volume: 17 year: 2016 ident: 415_CR225 publication-title: J. Headache Pain doi: 10.1186/s10194-016-0679-9 – volume: 13 start-page: 346 year: 2019 ident: 415_CR89 publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000504 – volume: 59 start-page: 306 year: 2019 ident: 415_CR8 publication-title: Headache doi: 10.1111/head.13459 – volume: 4 start-page: 5 year: 2000 ident: 415_CR166 publication-title: Eur. J. Pain doi: 10.1053/eujp.1999.0154 – volume: 153 start-page: 682 year: 2012 ident: 415_CR92 publication-title: Pain doi: 10.1016/j.pain.2011.12.008 – volume: 38 start-page: 1038 year: 2018 ident: 415_CR236 publication-title: Cephalalgia doi: 10.1177/0333102418762525 – volume: 135 start-page: 426 year: 2017 ident: 415_CR221 publication-title: Acta Neurol. Scand. doi: 10.1111/ane.12692 – volume: 30 start-page: 329 year: 2010 ident: 415_CR246 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01934.x – volume: 52 start-page: 233 year: 2015 ident: 415_CR253 publication-title: Noro Psikiyatr. Ars. doi: 10.5152/npa.2015.8799 – volume: 21 year: 2020 ident: 415_CR22 publication-title: J. Headache Pain doi: 10.1186/s10194-020-1081-1 – volume: 57 start-page: 1065 year: 2017 ident: 415_CR234 publication-title: Headache doi: 10.1111/head.13120 – volume: 81 start-page: 1261 year: 2010 ident: 415_CR177 publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.2009.198101 – volume: 34 start-page: 426 year: 2014 ident: 415_CR38 publication-title: Cephalalgia doi: 10.1177/0333102413515338 – volume: 185 start-page: 108456 year: 2021 ident: 415_CR127 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2021.108456 – volume: 22 year: 2021 ident: 415_CR88 publication-title: J. Headache Pain doi: 10.1186/s10194-021-01224-8 – volume: 40 start-page: 503 year: 2019 ident: 415_CR118 publication-title: Cephalalgia doi: 10.1177/0333102419883355 – volume: 22 year: 2022 ident: 415_CR53 publication-title: BMC Geriatrics doi: 10.1186/s12877-022-03027-1 – volume: 4 start-page: 55 year: 1992 ident: 415_CR124 publication-title: Patol. Fiziol. Eksp. Ter. – volume: 132 start-page: 126 year: 2021 ident: 415_CR231 publication-title: Clin. Neurophysiol. doi: 10.1016/j.clinph.2020.10.014 – volume: 6 start-page: 81 year: 2010 ident: 415_CR44 publication-title: Neuropsychiatr. Dis. Treat. doi: 10.2147/NDT.S8467 – volume: 59 start-page: 1481 year: 2019 ident: 415_CR48 publication-title: Headache doi: 10.1111/head.13641 – volume: 46 start-page: S88 year: 2006 ident: 415_CR98 publication-title: Headache doi: 10.1111/j.1526-4610.2006.00560.x – volume: 133 start-page: 2475 year: 2010 ident: 415_CR146 publication-title: Brain doi: 10.1093/brain/awq159 – volume: 27 start-page: 1102 year: 2020 ident: 415_CR198 publication-title: Eur. J. Neurol. doi: 10.1111/ene.14268 – ident: 415_CR56 – volume: 36 start-page: 1324 year: 2016 ident: 415_CR111 publication-title: Cephalalgia doi: 10.1177/0333102416630593 – volume: 40 start-page: 1717 year: 2019 ident: 415_CR97 publication-title: Neurol. Sci. doi: 10.1007/s10072-019-03865-9 – volume: 18 start-page: 329 year: 1980 ident: 415_CR84 publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(80)90306-7 – volume: 51 start-page: 9 year: 2015 ident: 415_CR143 publication-title: Neuropeptides doi: 10.1016/j.npep.2015.03.008 – volume: 89 start-page: 461 year: 2017 ident: 415_CR193 publication-title: Neurology doi: 10.1212/WNL.0000000000004177 – volume: 23 start-page: 982 year: 2003 ident: 415_CR209 publication-title: Cephalalgia doi: 10.1046/j.1468-2982.2003.00648.x – volume: 21 start-page: 544 year: 2021 ident: 415_CR100 publication-title: Exp. Ther. Med. doi: 10.3892/etm.2021.9976 – volume: 37 start-page: 1215 year: 2017 ident: 415_CR242 publication-title: Cephalalgia doi: 10.1177/0333102416672493 – volume: 135 start-page: 376 year: 2012 ident: 415_CR133 publication-title: Brain doi: 10.1093/brain/awr272 – volume: 39 start-page: 617 year: 2019 ident: 415_CR130 publication-title: Cephalalgia doi: 10.1177/0333102418804157 – volume: 386 start-page: 743 year: 2015 ident: 415_CR59 publication-title: Lancet doi: 10.1016/S0140-6736(15)60692-4 – volume: 8 start-page: 56 year: 2007 ident: 415_CR101 publication-title: J. Headache Pain doi: 10.1007/s10194-007-0361-3 – volume: 51 start-page: 197 year: 2021 ident: 415_CR125 publication-title: Neurophysiol. Clin. doi: 10.1016/j.neucli.2020.11.002 – volume: 40 start-page: 903 year: 2020 ident: 415_CR260 publication-title: Cephalalgia doi: 10.1177/0333102420920006 – volume: 42 start-page: 560 year: 2022 ident: 415_CR233 publication-title: Cephalalgia doi: 10.1177/03331024211068813 – volume: 119 start-page: 99 year: 2009 ident: 415_CR159 publication-title: J. Clin. Invest. – volume: 53 start-page: 665 year: 2013 ident: 415_CR249 publication-title: Headache doi: 10.1111/head.12031 – volume: 50 start-page: 464 year: 2014 ident: 415_CR179 publication-title: Pediatr. Neurol. doi: 10.1016/j.pediatrneurol.2014.01.040 – volume: 26 start-page: 1097 year: 2006 ident: 415_CR199 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2006.01175.x – volume: 29 start-page: 221 year: 2009 ident: 415_CR201 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2008.01711.x – volume: 20 year: 2019 ident: 415_CR16 publication-title: J. Headache Pain doi: 10.1186/s10194-019-1061-5 – volume: 97 start-page: e1661 year: 2021 ident: 415_CR107 publication-title: Neurology doi: 10.1212/WNL.0000000000012723 – volume: 331 start-page: 48 year: 2013 ident: 415_CR216 publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2013.05.003 – volume: 46 start-page: 3 year: 2006 ident: 415_CR104 publication-title: Headache doi: 10.1111/j.1526-4610.2006.00309.x – volume: 92 start-page: e2309 year: 2019 ident: 415_CR169 publication-title: Neurology doi: 10.1212/WNL.0000000000007497 – volume: 29 start-page: 30 year: 2015 ident: 415_CR178 publication-title: Br. J. Neurosurg. doi: 10.3109/02688697.2014.950633 – volume: 91 start-page: e364 year: 2018 ident: 415_CR237 publication-title: Neurology doi: 10.1212/WNL.0000000000005857 – volume: 38 start-page: 1 year: 2018 ident: 415_CR4 publication-title: Cephalalgia doi: 10.1177/0333102417738202 – volume: 61 start-page: 1021 year: 2021 ident: 415_CR174 publication-title: Headache doi: 10.1111/head.14153 – year: 2022 ident: 415_CR115 publication-title: Int. J. Neurosci. doi: 10.1080/00207454.2022.2126773 – volume: 18 year: 2017 ident: 415_CR21 publication-title: J. Headache Pain doi: 10.1186/s10194-017-0759-5 – volume: 262 start-page: 692 year: 1992 ident: 415_CR158 publication-title: J. Pharmacol. Exp. Ther. – volume: 30 start-page: S89 year: 2009 ident: 415_CR222 publication-title: Neurol. Sci. doi: 10.1007/s10072-009-0081-3 – volume: 30 start-page: 662 year: 2010 ident: 415_CR229 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.02022.x – volume: 40 start-page: 343 year: 2000 ident: 415_CR155 publication-title: Headache doi: 10.1046/j.1526-4610.2000.00052.x – ident: 415_CR83 doi: 10.1016/bs.pbr.2020.05.019 – volume: 86 start-page: 505 year: 2015 ident: 415_CR200 publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2014-308548 – volume: 394 start-page: 737 year: 2019 ident: 415_CR172 publication-title: Lancet doi: 10.1016/S0140-6736(19)31606-X – volume: 21 year: 2020 ident: 415_CR168 publication-title: J. Headache Pain doi: 10.1186/s10194-020-01173-8 – volume: 54 start-page: 152 year: 2022 ident: 415_CR77 publication-title: Nat. Genet. doi: 10.1038/s41588-021-00990-0 – volume: 10 start-page: 173 year: 2019 ident: 415_CR206 publication-title: Front. Neurol. doi: 10.3389/fneur.2019.00173 – volume: 34 start-page: 1 year: 1994 ident: 415_CR66 publication-title: Headache doi: 10.1111/j.1526-4610.1994.hed3401001.x – volume: 55 start-page: 128 year: 2015 ident: 415_CR213 publication-title: Headache doi: 10.1111/head.12487 – volume: 54 start-page: 211 year: 2014 ident: 415_CR76 publication-title: Headache doi: 10.1111/head.12223 – volume: 19 year: 2018 ident: 415_CR140 publication-title: J. Headache Pain doi: 10.1186/s10194-018-0848-0 – volume: 42 start-page: 197 year: 2022 ident: 415_CR132 publication-title: Cephalalgia doi: 10.1177/03331024211039813 – volume: 21 year: 2020 ident: 415_CR29 publication-title: J. Headache Pain doi: 10.1186/s10194-020-01146-x – volume: 58 start-page: 109 year: 2018 ident: 415_CR190 publication-title: Headache doi: 10.1111/head.13194 – volume: 36 start-page: 122 year: 2016 ident: 415_CR223 publication-title: Cephalalgia doi: 10.1177/0333102415583146 – volume: 34 start-page: 645 year: 2014 ident: 415_CR207 publication-title: Cephalalgia doi: 10.1177/0333102414521508 – volume: 21 start-page: 989 year: 2014 ident: 415_CR80 publication-title: Eur. J. Neurol. doi: 10.1111/ene.12424 – volume: 383 start-page: 1866 year: 2020 ident: 415_CR119 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1915327 – volume: 49 start-page: 412 year: 2009 ident: 415_CR96 publication-title: Headache doi: 10.1111/j.1526-4610.2008.01257.x – volume: 11 start-page: 216 year: 2021 ident: 415_CR256 publication-title: Neurol. Clin. Pract. doi: 10.1212/CPJ.0000000000001037 – volume: 39 start-page: 135 year: 2018 ident: 415_CR45 publication-title: Cephalalgia doi: 10.1177/0333102418783317 – volume: 29 start-page: 1496 year: 2022 ident: 415_CR162 publication-title: Eur. J. Neurol. doi: 10.1111/ene.15256 – volume: 29 start-page: 93 year: 2008 ident: 415_CR243 publication-title: Neurol. Sci. doi: 10.1007/s10072-008-0867-8 – volume: 40 start-page: 1202 year: 2020 ident: 415_CR230 publication-title: Cephalalgia doi: 10.1177/0333102420931050 – volume: 16 start-page: 73 year: 2012 ident: 415_CR93 publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-011-0240-0 – volume: 33 start-page: 132 year: 2021 ident: 415_CR250 publication-title: J. Neuropsychiatry Clin. Neurosci. doi: 10.1176/appi.neuropsych.20070189 – volume: 43 start-page: 635 year: 2020 ident: 415_CR106 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2020.06.003 – volume: 39 start-page: 274 year: 2019 ident: 415_CR183 publication-title: Cephalalgia doi: 10.1177/0333102418786265 – volume: 18 year: 2014 ident: 415_CR248 publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-014-0428-1 – volume: 96 year: 2017 ident: 415_CR254 publication-title: Medicine doi: 10.1097/MD.0000000000008493 – volume: 99 start-page: 529 year: 2000 ident: 415_CR142 publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00226-8 – volume: 25 start-page: 460 year: 2005 ident: 415_CR64 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2005.00878.x – ident: 415_CR180 – volume: 153 start-page: 56 year: 2012 ident: 415_CR9 publication-title: Pain doi: 10.1016/j.pain.2011.08.018 – volume: 32 start-page: 834 year: 2012 ident: 415_CR224 publication-title: Cephalalgia doi: 10.1177/0333102412451363 – volume: 35 start-page: 545 year: 2021 ident: 415_CR72 publication-title: CNS Drugs doi: 10.1007/s40263-021-00818-9 – volume: 18 start-page: 28 year: 2017 ident: 415_CR23 publication-title: J. Headache Pain doi: 10.1186/s10194-017-0734-1 – volume: 32 start-page: 373 year: 2012 ident: 415_CR20 publication-title: Cephalalgia doi: 10.1177/0333102412438977 – volume: 115 start-page: 208 year: 2016 ident: 415_CR150 publication-title: J. Neurophysiol. doi: 10.1152/jn.00632.2015 – volume: 13 start-page: 517 year: 2012 ident: 415_CR112 publication-title: World J. Biol. Psychiatry doi: 10.3109/15622975.2012.665175 – volume: 23 year: 2019 ident: 415_CR197 publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-019-0796-7 – volume: 40 start-page: 3 year: 2020 ident: 415_CR61 publication-title: Cephalalgia doi: 10.1177/0333102419876907 – volume: 129 start-page: 543 year: 2006 ident: 415_CR114 publication-title: Brain doi: 10.1093/brain/awh691 – volume: 12 start-page: 42 year: 2018 ident: 415_CR105 publication-title: Front. Integr. Neurosci. doi: 10.3389/fnint.2018.00042 – volume: 22 year: 2018 ident: 415_CR128 publication-title: Curr. Pain Headache Rep. doi: 10.1007/s11916-018-0734-0 – volume: 77 start-page: 1069 year: 2020 ident: 415_CR164 publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2020.1179 – volume: 48 start-page: 1157 year: 2008 ident: 415_CR6 publication-title: Headache doi: 10.1111/j.1526-4610.2008.01217.x – volume: 13 start-page: 255 year: 2012 ident: 415_CR117 publication-title: Pain Med. doi: 10.1111/j.1526-4637.2011.01183.x – volume: 15 year: 2014 ident: 415_CR187 publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-10 – volume: 80 start-page: 697 year: 2013 ident: 415_CR232 publication-title: Neurology doi: 10.1212/WNL.0b013e3182825055 – ident: 415_CR57 – volume: 24 start-page: 9 year: 2004 ident: 415_CR65 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2003.00824.x – volume: 32 start-page: 1189 year: 2012 ident: 415_CR78 publication-title: Cephalalgia doi: 10.1177/0333102412461890 – volume: 69 start-page: 26 year: 2007 ident: 415_CR210 publication-title: Neurology doi: 10.1212/01.wnl.0000263652.46222.e8 – volume: 52 start-page: 1350 year: 2012 ident: 415_CR137 publication-title: Headache doi: 10.1111/j.1526-4610.2012.02170.x – volume: 30 start-page: 1101 year: 2010 ident: 415_CR148 publication-title: Cephalalgia doi: 10.1177/0333102409355600 – volume: 67 start-page: 325 year: 2010 ident: 415_CR145 publication-title: Ann. Neurol. doi: 10.1002/ana.21897 – volume: 388 start-page: 1545 year: 2016 ident: 415_CR14 publication-title: Lancet doi: 10.1016/S0140-6736(16)31678-6 – volume: 42 start-page: 1246 year: 2022 ident: 415_CR28 publication-title: Cephalalgia doi: 10.1177/03331024221103814 – volume: 38 start-page: 1316 year: 2018 ident: 415_CR188 publication-title: Cephalalgia doi: 10.1177/0333102417736898 – volume: 124 start-page: 197 year: 2009 ident: 415_CR58 publication-title: Public Health Rep. doi: 10.1177/003335490912400206 – ident: 415_CR191 – volume: 23 year: 2022 ident: 415_CR26 publication-title: J. Headache Pain doi: 10.1186/s10194-022-01402-2 – volume: 12 start-page: 315 year: 2011 ident: 415_CR252 publication-title: J. Headache Pain doi: 10.1007/s10194-010-0285-1 – volume: 29 start-page: 1021 year: 2009 ident: 415_CR218 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2009.01859.x – volume: 88 start-page: 1250 year: 2017 ident: 415_CR238 publication-title: Neurology doi: 10.1212/WNL.0000000000003760 – volume: 381 start-page: 2230 year: 2019 ident: 415_CR258 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1813049 – volume: 16 start-page: 67 year: 2015 ident: 415_CR19 publication-title: J. Headache Pain doi: 10.1186/s10194-015-0549-x – volume: 5 start-page: 987 year: 2018 ident: 415_CR99 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(18)30337-7 – volume: 41 start-page: 340 year: 2021 ident: 415_CR167 publication-title: Cephalalgia doi: 10.1177/0333102420966658 – volume: 19 start-page: 14116 year: 2022 ident: 415_CR226 publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph192114116 – volume: 37 start-page: 1115 year: 2017 ident: 415_CR161 publication-title: Cephalalgia doi: 10.1177/0333102416660549 – volume: 48 start-page: 1026 year: 2008 ident: 415_CR91 publication-title: Headache doi: 10.1111/j.1526-4610.2007.00999.x – volume: 26 start-page: 62 year: 2005 ident: 415_CR147 publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2004.12.008 – volume: 33 start-page: 444 year: 2013 ident: 415_CR134 publication-title: Cephalalgia doi: 10.1177/0333102412475235 – volume: 8 start-page: 1 year: 1988 ident: 415_CR3 publication-title: Cephalalgia doi: 10.1046/j.1468-2982.1988.0801001.x – volume: 18 start-page: 891 year: 2019 ident: 415_CR71 publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(19)30146-2 – volume: 89 start-page: 1296 year: 2017 ident: 415_CR196 publication-title: Neurology doi: 10.1212/WNL.0000000000004371 – volume: 31 start-page: 161 year: 2011 ident: 415_CR247 publication-title: Cephalalgia doi: 10.1177/0333102410373155 – volume: 17 start-page: 107 year: 2016 ident: 415_CR182 publication-title: J. Headache Pain doi: 10.1186/s10194-016-0696-8 – volume: 15 year: 2014 ident: 415_CR69 publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-5 – volume: 142 start-page: 1203 year: 2019 ident: 415_CR163 publication-title: Brain doi: 10.1093/brain/awz052 – volume: 23 year: 2022 ident: 415_CR75 publication-title: J. Headache Pain doi: 10.1186/s10194-022-01471-3 – volume: 26 start-page: 153 year: 1951 ident: 415_CR1 publication-title: Proc. Staff. Meet. Mayo Clin. – volume: 61 start-page: 125 year: 2021 ident: 415_CR170 publication-title: Headache doi: 10.1111/head.14036 – volume: 61 start-page: 103 year: 2021 ident: 415_CR176 publication-title: Headache doi: 10.1111/head.14018 – volume: 9 start-page: 295 year: 2008 ident: 415_CR135 publication-title: J. Headache Pain doi: 10.1007/s10194-008-0061-7 – volume: 14 year: 2013 ident: 415_CR90 publication-title: J. Headache Pain doi: 10.1186/1129-2377-14-59 – volume: 54 start-page: 1019 year: 2014 ident: 415_CR189 publication-title: Headache doi: 10.1111/head.12350 – volume: 98 start-page: e1409 year: 2022 ident: 415_CR203 publication-title: Neurology doi: 10.1212/WNL.0000000000200117 – volume: 40 start-page: 892 year: 2020 ident: 415_CR171 publication-title: Cephalalgia doi: 10.1177/0333102420938652 – volume: 11 start-page: 226 year: 2020 ident: 415_CR239 publication-title: Front. Neurol. doi: 10.3389/fneur.2020.00226 – volume: 15 start-page: 245 year: 2012 ident: 415_CR228 publication-title: Pain Physician doi: 10.36076/ppj.2012/15/245 – volume: 23 start-page: 85 year: 2016 ident: 415_CR40 publication-title: Eur. J. Neurol. doi: 10.1111/ene.12794 – volume: 24 start-page: 483 year: 2004 ident: 415_CR7 publication-title: Cephalalgia doi: 10.1111/j.1468-2982.2004.00691.x – volume: 22 start-page: 37 year: 1980 ident: 415_CR85 publication-title: Adv. Biochem. Psychopharmacol. – volume: 7 start-page: 24 year: 2021 ident: 415_CR153 publication-title: Nat. Rev. Dis. Primers doi: 10.1038/s41572-021-00257-2 – volume: 360 start-page: eaap8757 year: 2018 ident: 415_CR87 publication-title: Science doi: 10.1126/science.aap8757 – volume: 19 start-page: 2575 year: 2018 ident: 415_CR240 publication-title: Pain Med. doi: 10.1093/pm/pny084 – volume: 17 year: 2016 ident: 415_CR37 publication-title: J. Headache Pain doi: 10.1186/s10194-016-0649-2 – volume: 61 start-page: 790 year: 2021 ident: 415_CR10 publication-title: Headache doi: 10.1111/head.14108 – volume: 22 start-page: 1228 year: 2015 ident: 415_CR52 publication-title: Eur. J. Neurol. doi: 10.1111/ene.12732 – volume: 62 start-page: 890 year: 2022 ident: 415_CR181 publication-title: Headache doi: 10.1111/head.14363 – volume: 61 start-page: 351 year: 2021 ident: 415_CR49 publication-title: Headache doi: 10.1111/head.14056 – volume: 59 start-page: 1011 year: 2002 ident: 415_CR175 publication-title: Neurology doi: 10.1212/WNL.59.7.1011 – volume: 34 start-page: 594 year: 2014 ident: 415_CR149 publication-title: Cephalalgia doi: 10.1177/0333102413515344 – ident: 415_CR13 – volume: 41 start-page: 1053 year: 2021 ident: 415_CR46 publication-title: Cephalalgia doi: 10.1177/03331024211006903 – volume: 22 year: 2021 ident: 415_CR42 publication-title: J. Headache Pain doi: 10.1186/s10194-021-01248-0 – volume: 38 start-page: 225 year: 2018 ident: 415_CR204 publication-title: Cephalalgia doi: 10.1177/0333102417737779 – volume: 21 year: 2020 ident: 415_CR30 publication-title: J. Headache Pain doi: 10.1186/s10194-020-01175-6 – volume: 31 start-page: 851 year: 2011 ident: 415_CR131 publication-title: Cephalalgia doi: 10.1177/0333102411402367 – volume: 18 year: 2017 ident: 415_CR139 publication-title: J. Headache Pain doi: 10.1186/s10194-017-0741-2 – volume: 50 start-page: 1464 year: 2010 ident: 415_CR54 publication-title: Headache doi: 10.1111/j.1526-4610.2010.01711.x – volume: 18 year: 2017 ident: 415_CR212 publication-title: J. Headache Pain doi: 10.1186/s10194-017-0763-9 – volume: 10 start-page: 349 year: 2009 ident: 415_CR79 publication-title: J. Headache Pain doi: 10.1007/s10194-009-0136-0 – volume: 36 start-page: 371 year: 2016 ident: 415_CR202 publication-title: Cephalalgia doi: 10.1177/0333102415593088 – volume: 28 start-page: 284 year: 2012 ident: 415_CR251 publication-title: Clin. J. Pain doi: 10.1097/AJP.0b013e3182321d35 – volume: 17 start-page: 110 year: 2016 ident: 415_CR25 publication-title: J. Headache Pain doi: 10.1186/s10194-016-0704-z – volume: 16 year: 2015 ident: 415_CR18 publication-title: J. Headache Pain doi: 10.1186/s10194-015-0580-y – volume: 10 year: 2010 ident: 415_CR152 publication-title: BMC Neurol. doi: 10.1186/1471-2377-10-126 – volume: 19 start-page: 703 year: 2012 ident: 415_CR60 publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2011.03612.x – volume: 280 start-page: 934 year: 1997 ident: 415_CR156 publication-title: J. Pharmacol. Exp. Ther. – volume: 15 start-page: 86 year: 2014 ident: 415_CR32 publication-title: J. Headache Pain doi: 10.1186/1129-2377-15-86 – volume: 54 start-page: 1251 year: 2014 ident: 415_CR165 publication-title: Headache doi: 10.1111/head.12408 – volume: 47 start-page: 170 year: 2007 ident: 415_CR217 publication-title: Headache doi: 10.1111/j.1526-4610.2006.00684.x – volume: 14 year: 2013 ident: 415_CR160 publication-title: J. Headache Pain doi: 10.1186/1129-2377-14-10 – volume: 92 start-page: 134 year: 2019 ident: 415_CR184 publication-title: Neurology doi: 10.1212/WNL.0000000000006697 – volume: 52 start-page: 18 year: 2012 ident: 415_CR94 publication-title: Headache doi: 10.1111/j.1526-4610.2011.02050.x – volume: 41 start-page: 643 year: 2021 ident: 415_CR102 publication-title: Cephalalgia doi: 10.1177/0333102420974362 – volume: 43 start-page: 179 year: 2003 ident: 415_CR74 publication-title: Headache doi: 10.1046/j.1526-4610.2003.03041.x – volume: 21 start-page: 878 year: 2001 ident: 415_CR245 publication-title: Cephalalgia doi: 10.1046/j.1468-2982.2001.00288.x – volume: 12 start-page: 575 year: 2016 ident: 415_CR47 publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2016.124 – volume: 26 start-page: 1202 year: 2018 ident: 415_CR86 publication-title: Eur. J. Hum. Genet. doi: 10.1038/s41431-018-0150-2 |
SSID | ssj0001586986 |
Score | 2.519827 |
SecondaryResourceType | review_article |
Snippet | Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5 |
SubjectTerms | 631/378 692/617/375/226 Cancer Research Epidemiology Headache - etiology Headache Disorders, Secondary - diagnosis Headaches Humans Internal Medicine Medical Microbiology Medicine Medicine & Public Health Migraine Migraine Disorders - diagnosis Migraine Disorders - drug therapy Primer Quality of Life Quality of Life Research |
Title | Medication overuse headache |
URI | https://link.springer.com/article/10.1038/s41572-022-00415-0 https://www.ncbi.nlm.nih.gov/pubmed/36732518 https://www.proquest.com/docview/2771822419 https://www.proquest.com/docview/2773121006 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB7UgngR39ZHieBB0cUku9nHSVSUIlSKWOgtZDebk7Rq2__vTLJtEdFjyCZZZmZnPmYm3wCcVwiSlagKhmC1YkK6hBk0JFY5Y5xT1lSeEvq9F9kdiOdhNgwJt0loq5z7xNpRl2NHOfKbVKEXpXhjbj8-GU2NoupqGKGxCi2iLqOWLjVUyxxLpqXRMvwrE3N9M8F4pVJGLezENJWx-Gc8-gUyfxVI67jztAWbATBGd42Gt2HFj3ZgvRdK4rtw3pRaSL4RtWPOJj5CB1sSUXN00Sf2_q_LPRg8Pb49dFkYfcAcV9mUybgUWWm0k8KlBbfWcGdj9EV4YogQHkFMQkQsXgmRpoWMUa6ZtggerCw1Htt9WBuNR_4QoqK0XvKKel8y4ZWxqUoSJwqb4AUCnjYkcwHkLvCC03iK97yuT3OdN0LLUWh5LbQ8bsPV4pmPhhXj39Unc7nm4YRM8qU-23C2uI22TQWLYuTHs3oNJ4KzGDd50Ohj8TkuFUdspttwPVfQ8uV_7-Xo_70cwwbNk6d-lVSfwNr0a-ZPEXVMbac2rQ607h9f-q_faonP7A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LaxsxEB5cG9pcSvqMW6fdQgotjciupJVWh1D6SHDq2ISSQG7qSqs9FTuNbUL-VH9jZvZhU0Jzy3FZrVbM85NmNAOwUyJI1rLMGYLVkknlE2ZQkFjpjfFeO1MGOtAfT9TwTP44T8878Le9C0Npla1NrAx1MfN0Rr7HNVpR8jfm88UfRl2jKLrattCoxWIUrq9wyzbfP_qO_H3P-eHB6bcha7oKMC90umAqLmRamMwr6XkunDPCuxjVHIWRaq0jPkioxknQUnKeqxiXnGYO_bJTRYYagfM-gJ4UuJXpQu_rweTk5_pUJ82UyVRzOycW2d4cPaTmjJLmqbZVyuJ_PeAtWHsrJFt5usNNeNxA1OhLLVNPoBOmT-HhuAnCP4OdOrhDHI0oAXQ5DxGa9IJKQ0cfTqhfwOXH53B2L2R5Ad3pbBq2IMoLF5QoKdsmlUEbx3WSeJm7BB8QYvUhaQlgfVOJnBpi_LZVRFxktiaaRaLZimg27sOn1TcXdR2OO0cPWrraRifndi1BfXi3eo3aRCGSfBpmy2qMoJJqMS7yZc2P1e-E0gLRYNaH3ZZB68n_v5ZXd6_lLTwano6P7fHRZPQaNqibfZUUzgfQXVwuwzZinoV70whaBL_uW7ZvAAy4Cnc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medication+overuse+headache&rft.jtitle=Nature+reviews.+Disease+primers&rft.au=Ashina%2C+Sait&rft.au=Terwindt%2C+Gisela+M&rft.au=Steiner%2C+Timothy+J&rft.au=Lee%2C+Mi+Ji&rft.date=2023-02-02&rft.eissn=2056-676X&rft.volume=9&rft.issue=1&rft.spage=5&rft_id=info:doi/10.1038%2Fs41572-022-00415-0&rft_id=info%3Apmid%2F36732518&rft.externalDocID=36732518 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-676X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-676X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-676X&client=summon |